To O
clarify O
the O
difference O
, O
both O
the O
Crk B
II I
and O
Crk B
II I
- I
23 I
, O
proteins O
were O
expressed O
in O
E O
. O
coli O
and O
examined O
their O
binding O
capacity O
in O
vitro O
. O

Id B
- I
1H I
and O
Id B
- I
2H I
seem O
to O
be O
human O
homologues O
of O
mouse B
Id I
- I
1 I
and O
Id B
- I
2 I
, O
respectively O
, O
and O
have O
potential O
to O
encode O
154 O
and O
135 O
amino O
acid O
proteins O
. O

Alternative O
splicing O
of O
the O
human B
serotonin I
transporter I
gene I
. O

Several O
studies O
have O
demonstrated O
that O
the O
corticotropin B
- I
releasing I
factor I
test O
( O
CRF B
) O
is O
useful O
for O
the O
aetiological O
diagnosis O
of O
Cushing O
' O
s O
syndrome O
: O
in O
Cushing O
' O
s O
disease O
, O
as O
opposed O
to O
ectopic O
ACTH B
secretion O
syndrome O
, O
the O
hypothalamus O
- O
pituitary O
- O
adrenal O
( O
HPA O
) O
axis O
can O
still O
be O
stimulated O
by O
CRF B
. O

The O
results O
of O
the O
transient O
- O
transfection O
assay O
showed O
that O
the O
Sp1 B
binding I
element I
located O
in O
the O
core O
region O
( O
positions O
- O
- O
64 O
to O
+ O
1 O
) O
of O
the O
alpha2 B
- I
integrin I
promoter I
plays O
an O
essential O
role O
in O
the O
alpha2 B
- I
integrin I
promoter I
activity O
and O
its O
downregulation O
by O
Erb B
- O
B2 B
. O

The O
results O
of O
the O
transient O
- O
transfection O
assay O
showed O
that O
the O
Sp1 B
binding I
element I
located O
in O
the O
core O
region O
( O
positions O
- O
- O
64 O
to O
+ O
1 O
) O
of O
the O
alpha2 B
- I
integrin I
promoter I
plays O
an O
essential O
role O
in O
the O
alpha2 B
- I
integrin I
promoter I
activity O
and O
its O
downregulation O
by O
Erb B
- O
B2 B
. O

Interaction O
of O
the O
v B
- I
rel I
protein I
with O
an O
NF B
- I
kappa I
B I
DNA I
binding I
site I
. O

First O
, O
a O
GATA B
- I
1 I
motif I
was O
found O
to O
bind O
nuclear O
factor O
( O
s O
) O
, O
presumably O
the O
GATA B
- I
1 I
factor I
, O
present O
in O
K O
- O
562 O
cell O
extracts O
and O
in O
living O
K O
- O
562 O
cells O
. O

First O
, O
a O
GATA B
- I
1 I
motif I
was O
found O
to O
bind O
nuclear O
factor O
( O
s O
) O
, O
presumably O
the O
GATA B
- I
1 I
factor I
, O
present O
in O
K O
- O
562 O
cell O
extracts O
and O
in O
living O
K O
- O
562 O
cells O
. O

This O
inhibition O
was O
due O
to O
competition O
from O
the O
EMC O
virus O
IRES O
present O
in O
pEP B
- I
2A I
transcripts I
, O
as O
well O
as O
the O
expression O
of O
proteolytically O
active O
2Apro B
. O

The O
GST B
- O
CBL B
- O
LZIP B
fusion O
protein O
contains O
a O
binding O
site O
for O
the O
SH2 B
domain I
of O
the O
p85 B
subunit I
of O
phosphatidylinositol B
3 I
- I
kinase I
, O
which O
mapped O
to O
Tyr731 O
, O
which O
is O
present O
in O
the O
sequence O
YEAM O
. O

A O
Brassica O
cDNA O
clone O
encoding O
a O
bifunctional O
hydroxymethylpyrimidine B
kinase I
/ O
thiamin B
- I
phosphate I
pyrophosphorylase I
involved O
in O
thiamin O
biosynthesis O
. O

The O
unc B
- I
101 I
, O
sli B
- I
1 I
, O
and O
rok B
- I
1 I
genes I
encode O
a O
distinct O
set O
of O
negative O
regulators O
of O
vulval O
differentiation O
. O

The O
elevated O
levels O
of O
inositol O
phosphates O
resulting O
from O
N B
( I
epi I
) I
alpha I
qQ209L I
expression O
were O
similar O
to O
those O
obtained O
with O
carbachol O
activation O
of O
the O
M1 B
muscarinic I
acetylcholine I
receptor I
. O

Comparison O
of O
the O
encoded O
ERCC3Dm B
protein I
with O
the O
homologous O
proteins O
of O
mouse O
and O
man O
shows O
a O
strong O
amino O
acid O
conservation O
( O
71 O
% O
identity O
) O
, O
especially O
in O
the O
postulated O
DNA O
binding O
region O
and O
seven O
' B
helicase I
' I
domains I
. O

The O
zinc B
finger I
protein I
A20 I
is O
a O
tumor B
necrosis I
factor I
( O
TNF B
) O
- O
and O
interleukin B
1 I
( O
IL B
- I
1 I
) O
- O
inducible O
protein O
that O
negatively O
regulates O
nuclear B
factor I
- I
kappa I
B I
( O
NF B
- I
kappaB I
) O
- O
dependent O
gene O
expression O
. O

At O
least O
one O
such O
complex O
is O
eliminated O
by O
preincubating O
the O
nuclear O
extract O
with O
an O
antibody O
with O
broad O
cross O
- O
reactivity O
with O
Ets B
- I
1 I
and O
Ets B
- I
2 I
proteins I
, O
thus O
confirming O
that O
an O
ETS B
transcription I
factor I
( I
s I
) I
recognizes O
the O
- O
12 O
motif O
. O

Mutant O
beta2 B
- I
adrenergic I
receptors I
with O
a O
Tyr O
- O
to O
- O
Phe O
substitution O
at O
Tyr O
- O
350 O
do O
not O
display O
agonist O
- O
induced O
desensitization O
, O
Src B
recruitment O
, O
or O
Src B
activation O
. O

These O
data O
may O
indicate O
redundancy O
between O
members O
of O
the O
NGFI B
- I
B I
/ O
Nurr1 B
/ O
Nor1 B
subfamily O
and O
could O
explain O
why O
no O
phenotypic O
disturbances O
have O
yet O
been O
found O
in O
mice O
in O
which O
the O
NGFI B
- I
B I
gene I
has O
been O
inactivated O
. O

These O
results O
indicate O
that O
H B
- I
2RIIBP I
( O
i O
) O
is O
a O
member O
of O
the O
superfamily O
of O
nuclear B
hormone I
receptors I
and O
( O
ii O
) O
may O
regulate O
not O
only O
MHC B
class I
I I
genes I
but O
also O
genes O
containing O
the O
ERE O
and O
related O
sequences O
. O

The O
Aspergillus B
uvsH I
gene I
encodes O
a O
product O
homologous O
to O
yeast B
RAD18 I
and O
Neurospora B
UVS I
- I
2 I
. O

In O
human O
WI38 O
cells O
, O
the O
E1B B
19K I
gene I
mutant I
viruses O
had O
a O
substantial O
growth O
advantage O
over O
the O
wild O
- O
type O
virus O
, O
yielding O
500 O
- O
fold O
- O
higher O
titers O
. O

To O
elucidate O
the O
mechanism O
of O
these O
hormonal O
effects O
, O
we O
have O
studied O
the O
regulatory O
regions O
of O
the O
PFK B
- I
2 I
gene I
in O
transfection O
experiments O
. O

Consequently O
, O
during O
the O
evolution O
of O
mammals O
, O
it O
is O
the O
CKbeta4GT B
- I
I I
gene I
lineage O
that O
has O
been O
recruited O
for O
the O
biosynthesis O
of O
lactose O
. O

The O
preference O
for O
third O
base O
codon O
in O
Y O
position O
prolines O
is O
U O
for O
the O
alpha B
2 I
( I
VI I
) I
collagen I
as O
it O
is O
for O
the O
human B
fibrillar I
collagen I
genes I
. O

However O
, O
electron O
microscopy O
revealed O
that O
while O
sec4 B
mutant I
cells O
accumulate O
secretory O
vesicles O
, O
ypt31 B
/ I
32 I
mutant I
cells O
accumulate O
aberrant O
Golgi O
structures O
. O

We O
show O
that O
the O
upstream O
region O
of O
the O
beta B
- I
MyHC I
gene I
( O
- O
5518 O
to O
- O
2490 O
relative O
to O
the O
transcriptional O
start O
site O
) O
directed O
high O
levels O
of O
transcriptional O
activity O
only O
when O
stably O
integrated O
, O
but O
not O
when O
expressed O
extrachromosomally O
in O
transient O
assays O
. O

The O
temporal O
changes O
in O
the O
plasma O
concentration O
of O
immunoreactive B
atrial I
natriuretic I
factor I
( O
iANF B
) O
were O
studied O
in O
six O
conscious O
dogs O
with O
an O
arteriovenous O
( O
AV O
) O
fistula O
, O
a O
model O
of O
chronic O
high O
- O
output O
heart O
failure O
. O

Cytokine O
- O
mediated O
I B
kappa I
B I
alpha I
reappearance O
was O
completely O
blocked O
by O
the O
protein O
synthesis O
inhibitor O
cycloheximide O
. O

Non O
- O
finger O
- O
coding O
modules O
conserved O
among O
members O
of O
subfamilies O
of O
zinc B
finger I
genes I
have O
been O
described O
in O
the O
murine O
genome O
( O
finger O
- O
associated O
boxes O
, O
or O
FAX O
domain O
) O
and O
the O
human O
genome O
( O
Kruppel B
- I
associated I
boxes I
, O
or O
KRAB B
domain I
) O
. O

Comparison O
of O
the O
5 O
' O
flanking O
regions O
of O
the O
mouse B
J I
kappa I
elements I
, O
including O
the O
conserved O
putative O
recombination O
target O
sequences O
, O
shows O
no O
obvious O
differences O
consistent O
with O
the O
variation O
in O
recombinational O
efficiency O
, O
so O
we O
conclude O
that O
, O
although O
the O
consensus O
heptamer O
and O
nonamer O
signals O
may O
be O
sufficient O
to O
identify O
a O
recombination O
site O
, O
the O
probability O
that O
that O
site O
will O
be O
used O
depends O
also O
on O
other O
determinants O
. O

To O
clarify O
the O
mechanisms O
that O
regulate O
transcription O
of O
the O
GTP B
cyclohydrolase I
I I
gene I
and O
to O
generate O
multiple O
species O
of O
mRNA O
, O
we O
isolated O
genomic O
DNA O
clones O
for O
the O
human O
and O
mouse O
GTP B
cyclohydrolase I
I I
genes I
. O

To O
clarify O
the O
mechanisms O
that O
regulate O
transcription O
of O
the O
GTP B
cyclohydrolase I
I I
gene I
and O
to O
generate O
multiple O
species O
of O
mRNA O
, O
we O
isolated O
genomic O
DNA O
clones O
for O
the O
human O
and O
mouse O
GTP B
cyclohydrolase I
I I
genes I
. O

On O
the O
basis O
of O
this O
homology O
, O
we O
examined O
the O
potential O
role O
of O
c B
- I
Rel I
in O
controlling O
IL B
- I
2R I
alpha I
transcription O
. O

Epstein B
- I
Barr I
virus I
nuclear I
antigen I
2 I
exerts O
its O
transactivating O
function O
through O
interaction O
with O
recombination B
signal I
binding I
protein I
RBP I
- I
J I
kappa I
, O
the O
homologue O
of O
Drosophila B
Suppressor I
of I
Hairless I
. O

Serum B
alpha I
- I
amylase I
, O
trypsin B
, O
trypsin B
inhibitor I
, O
lipase B
and O
total O
protease O
activity O
in O
the O
pancreatic O
tissue O
was O
studied O
as O
indicator O
of O
the O
treatment O
efficacy O
with O
5 O
- O
fluorouracil O
electro O
- O
cumulation O
. O

The O
interleukin B
- I
2 I
receptor I
alpha I
( O
IL B
- I
2R I
alpha I
) O
chain O
gene O
contains O
a O
sequence O
similar O
to O
the O
immunoglobulin B
( I
Ig I
) I
kappa I
( O
kappa O
) O
enhancer O
NF B
- I
kappa I
B I
binding I
site I
. O

Comparison O
of O
the O
derived O
amino O
acid O
sequence O
with O
that O
of O
the O
HCMV B
UL99 I
gene I
product I
reveals O
34 O
. O
8 O
% O
identity O
in O
an O
overlap O
of O
66 O
amino O
acids O
. O

In O
analogy O
to O
human B
CD70 I
, O
mCD70 B
transcript I
levels O
are O
strongly O
but O
transiently O
up O
- O
regulated O
during O
lymphocyte O
activation O
, O
which O
is O
in O
line O
with O
a O
role O
for O
the O
CD27 B
- I
CD70 I
receptor I
pair O
early O
in O
the O
immune O
response O
. O

The O
matrix O
of O
the O
CBs O
contains O
the O
diagnostic O
protein O
p80 B
- O
coilin B
, O
which O
is O
colocalized O
with O
the O
U7 B
small I
nuclear I
ribonucleoprotein I
( O
snRNP O
) O
, O
whereas O
the O
attached O
and O
embedded O
B O
- O
snurposomes O
contain O
splicing O
snRNPs O
. O

We O
also O
show O
that O
an O
internal O
fragment O
of O
U24 B
methylation I
guide I
snoRNA I
, O
encompassing O
the O
upstream O
antisense O
element O
and O
the O
D O
' O
and O
C O
' O
box O
motifs O
, O
can O
support O
the O
site O
- O
specific O
methylation O
of O
rRNA O
. O

Recombinant B
MsERK1 I
( O
rMsERK1 B
) O
, O
when O
overexpressed O
in O
Escherichia O
coli O
, O
is O
recognized O
by O
antibodies O
raised O
against O
MAP B
kinases I
from I
rat I
, I
Xenopus I
, I
and I
sea I
star I
and O
by O
anti B
- I
phosphotyrosine I
antibodies I
. O

We O
previously O
demonstrated O
that O
AKT2 B
, O
a O
member O
of O
protein B
kinase I
B I
family I
, O
is O
activated O
by O
a O
number O
of O
growth O
factors O
via O
Ras B
and O
PI B
3 I
- I
kinase I
signaling O
pathways O
. O

We O
previously O
demonstrated O
that O
AKT2 B
, O
a O
member O
of O
protein B
kinase I
B I
family I
, O
is O
activated O
by O
a O
number O
of O
growth O
factors O
via O
Ras B
and O
PI B
3 I
- I
kinase I
signaling O
pathways O
. O

Its O
phosphorylation O
strongly O
potentiates O
its O
ability O
to O
activate O
transcription O
of O
the O
c B
- I
fos I
promoter I
through O
a O
ternary O
complex O
assembled O
on O
the O
c B
- I
fos I
serum I
response I
element I
. O

Human B
epidermal I
growth I
factor I
( O
EGF B
) O
, O
a O
naturally O
occurring O
protein O
, O
has O
been O
implicated O
in O
the O
protection O
of O
gastrointestinal O
mucosal O
integrity O
. O

Site O
- O
directed O
mutagenesis O
of O
the O
T4 B
endonuclease I
V I
gene I
: O
role O
of O
lysine O
- O
130 O
. O

The O
library O
will O
thus O
be O
useful O
for O
the O
selection O
of O
cosmid O
clones O
which O
carry O
CDC B
genes I
from I
yeast I
by O
complementing O
first O
, O
with O
the O
vectorial O
yeast B
gene I
URA1 I
, O
the O
pyrimidine O
auxotrophy O
of O
most O
cdc B
- O
strains O
and O
then O
, O
with O
the O
respective O
CDC B
wild I
- I
type I
genes I
, O
of O
the O
temperature O
- O
sensitive O
mutant O
alleles O
. O

In O
addition O
, O
both O
activated O
Ral B
- I
GDS I
- I
like I
factor O
and O
Raf B
stimulate O
cyclin B
D I
( I
1 I
) I
transcription O
and O
E2F B
activity O
and O
act O
in O
synergy O
with O
PI B
3 I
- I
kinase I
. O

Down O
- O
regulation O
of O
Id1 B
mRNA I
correlated O
with O
mitogenesis O
and O
occurred O
when O
quiescent O
cells O
were O
treated O
with O
growth O
factors O
that O
activate O
G B
protein I
- I
coupled I
receptors I
and O
receptor B
protein I
tyrosine I
kinases I
but O
not O
with O
a O
non O
- O
mitogenic O
cAMP O
analog O
. O

BK B
- O
induced O
translocation O
and O
overexpression O
of O
PKC B
isoforms I
as O
well O
as O
coexpression O
of O
inactive O
or O
constitutively O
active O
mutants O
of O
different O
PKC B
isozymes I
provided O
evidence O
for O
a O
role O
of O
the O
diacylglycerol O
- O
sensitive O
PKCs B
alpha I
and I
epsilon I
in O
BK B
signaling O
toward O
MAPK B
. O

Analysis O
of O
deletion O
and O
substitution O
mutations O
in O
the O
MER2 B
5 I
' I
exon I
demonstrates O
that O
the O
unusually O
large O
size O
of O
this O
exon O
plays O
an O
important O
role O
in O
splicing O
regulation O
. O

Reexamination O
of O
the O
cdc4 B
- I
1 I
mutant I
revealed O
that O
, O
in O
addition O
to O
being O
defective O
in O
the O
onset O
of O
S O
phase O
, O
it O
is O
also O
defective O
in O
G O
( O
2 O
) O
/ O
M O
transition O
when O
released O
from O
hydroxyurea O
- O
induced O
S O
- O
phase O
arrest O
. O

A O
single O
clone O
, O
which O
was O
conserved O
and O
had O
near O
- O
perfect O
homology O
to O
eight O
human O
/ O
rodent O
expressed O
sequence O
tags O
, O
was O
used O
as O
template O
for O
5 O
' O
and O
3 O
' O
rapid O
amplification O
of O
cDNA O
ends O
and O
SPICE O
( O
system O
for O
polymerase O
chain O
reaction O
amplification O
of O
cDNA O
ends O
) O
reactions O
to O
obtain O
the O
3 O
. O
6 O
- O
kb O
cDNA O
, O
LGL2 B
( O
Genbank B
, I
AF I
110195 I
) O
encoding O
a O
deduced O
polypeptide O
( O
lgl2 B
) O
of O
963 O
amino O
acids O
. O

Human B
parvovirus I
B19 I
gene I
expression O
from O
the O
viral B
p6 I
promoter I
( O
B19p6 B
) O
is O
restricted O
to O
primary O
human O
hematopoietic O
cells O
undergoing O
erythroid O
differentiation O
. O

In O
summary O
, O
FGFR3 B
signaling O
pathway O
utilizes O
two O
GRB2 B
- I
containing I
complexes I
; O
Shc B
. O
GRB2 B
. O
Sos B
and O
80K B
- I
H I
. O
pp66 B
. O
GRB2 B
. O
Sos B
; O
these O
two O
complexes O
may O
alternatively O
link O
FGFG3 B
to O
mitogen B
- I
activated I
protein I
kinase I
. O

Four O
families O
of O
homing B
endonucleases I
have O
been O
identified O
, O
including O
the O
LAGLIDADG B
, O
the O
His B
- I
Cys I
box I
, O
the O
GIY B
- I
YIG I
and O
the O
H B
- I
N I
- I
H I
endonucleases I
. O

Increased O
TRE O
DNA O
binding O
failed O
to O
lead O
to O
increased O
transactivation O
correlating O
with O
the O
inability O
of O
SB O
203580 O
to O
increase O
phosphorylation O
of O
these O
AP B
- I
1 I
proteins I
. O

However O
, O
and O
in O
contrast O
to O
other O
MMP B
genes I
, O
no O
significative O
synergistic O
effect O
on O
CAT B
activity O
between O
the O
AP B
- I
1 I
and O
PEA B
- I
3 I
elements I
found O
in O
the O
collagenase B
- I
3 I
gene I
promoter I
was O
found O
. O

Twelve O
patients O
of O
leprosy O
with O
arthritis O
and O
161 O
patients O
without O
arthritis O
were O
studied O
for O
immunological O
parameters O
like O
immunoglobulins B
( O
IgG B
, O
IgM B
, O
IgA B
) O
, O
C B
- I
reactive I
proteins I
and O
rheumatoid B
factor I
. O

Several O
reports O
assert O
that O
prolactin B
affects O
the O
delta O
5 O
and O
delta O
4 O
pathways O
through O
its O
effect O
on O
the O
activity O
of O
3beta B
- I
hydroxysteroid I
dehydrogenase I
( O
3beta B
- I
OHSD I
) O
. O

The O
NrfC B
polypeptide I
, O
M B
( I
r I
) I
24 I
, I
567 I
, O
contains O
16 O
cysteine O
residues O
arranged O
in O
four O
clusters O
typical O
of O
the O
CooF B
super I
- I
family I
of O
non O
- O
haem O
iron O
- O
sulphur O
proteins O
. O

( O
i O
) O
p60 B
bound O
fast O
- O
migrating O
, O
underprocessed O
wild B
- I
type I
ICP22 I
and O
ICP22 B
lacking O
the O
carboxyl O
- O
terminal O
24 O
amino O
acids O
but O
not O
ICP22 B
lacking O
the O
carboxyl O
- O
terminal O
40 O
amino O
acids O
, O
whereas O
the O
previously O
identified O
cellular B
protein I
p78 I
( O
R O
. O

ORF3 O
appears O
to O
encode O
the O
homologue O
of O
the O
well O
- O
conserved O
proteasomal B
26S I
regulatory I
subunit I
. O

Mouse B
macrophage I
beta I
subunit I
( I
CD11b I
) I
cDNA I
for O
the O
CR3 B
complement I
receptor I
/ O
Mac B
- I
1 I
antigen I
. O

Cbl B
is O
a O
signaling O
molecule O
with O
multiple O
functional O
domains O
: O
an O
SH2 B
domain I
which O
binds O
phosphotyrosine O
residues O
, O
a O
RING O
finger O
domain O
which O
acts O
as O
a O
ubiquitin B
ligase I
, O
a O
proline O
- O
rich O
region O
which O
serves O
as O
a O
docking O
site O
for O
SH3 B
- I
containing I
proteins I
, O
phosphotyrosine O
residues O
which O
serve O
as O
docking O
sites O
for O
SH2 B
- I
containing I
proteins I
such O
a O
CrkL B
and O
the O
p85 B
subunit I
of O
PI B
3 I
- I
kinase I
, O
and O
a O
nuclear O
localization O
signal O
. O

Cbl B
is O
a O
signaling O
molecule O
with O
multiple O
functional O
domains O
: O
an O
SH2 B
domain I
which O
binds O
phosphotyrosine O
residues O
, O
a O
RING O
finger O
domain O
which O
acts O
as O
a O
ubiquitin B
ligase I
, O
a O
proline O
- O
rich O
region O
which O
serves O
as O
a O
docking O
site O
for O
SH3 B
- I
containing I
proteins I
, O
phosphotyrosine O
residues O
which O
serve O
as O
docking O
sites O
for O
SH2 B
- I
containing I
proteins I
such O
a O
CrkL B
and O
the O
p85 B
subunit I
of O
PI B
3 I
- I
kinase I
, O
and O
a O
nuclear O
localization O
signal O
. O

Cbl B
is O
a O
signaling O
molecule O
with O
multiple O
functional O
domains O
: O
an O
SH2 B
domain I
which O
binds O
phosphotyrosine O
residues O
, O
a O
RING O
finger O
domain O
which O
acts O
as O
a O
ubiquitin B
ligase I
, O
a O
proline O
- O
rich O
region O
which O
serves O
as O
a O
docking O
site O
for O
SH3 B
- I
containing I
proteins I
, O
phosphotyrosine O
residues O
which O
serve O
as O
docking O
sites O
for O
SH2 B
- I
containing I
proteins I
such O
a O
CrkL B
and O
the O
p85 B
subunit I
of O
PI B
3 I
- I
kinase I
, O
and O
a O
nuclear O
localization O
signal O
. O

GAGA B
factor I
is O
known O
to O
remodel O
the O
chromatin O
structure O
in O
concert O
with O
nucleosome B
- I
remodeling I
factor I
NURF B
in O
a O
Drosophila O
embryonic O
S150 O
extract O
. O

The O
selective O
5 B
- I
HT2 I
receptor I
blocker O
ketanserin O
was O
found O
to O
reduce O
maximal O
urethral O
pressures O
in O
healthy O
females O
by O
about O
40 O
% O
without O
reducing O
blood O
pressure O
. O

Siglec B
- I
9 I
is O
predicted O
to O
contain O
three O
extracellular O
immunoglobulin B
- I
like I
domains I
that O
comprise O
an O
N B
- I
terminal I
V I
- I
set I
domain I
and O
two O
C2 B
- I
set I
domains I
, O
a O
transmembrane O
region O
and O
a O
cytoplasmic O
tail O
containing O
two O
putative O
tyrosine O
- O
based O
signaling O
motifs O
. O

Siglec B
- I
9 I
is O
predicted O
to O
contain O
three O
extracellular O
immunoglobulin B
- I
like I
domains I
that O
comprise O
an O
N B
- I
terminal I
V I
- I
set I
domain I
and O
two O
C2 B
- I
set I
domains I
, O
a O
transmembrane O
region O
and O
a O
cytoplasmic O
tail O
containing O
two O
putative O
tyrosine O
- O
based O
signaling O
motifs O
. O

We O
demonstrate O
that O
the O
WRM B
- I
1 I
protein I
binds O
to O
LIT B
- I
1 I
in O
vivo O
and O
that O
WRM B
- I
1 I
can O
activate O
the O
LIT B
- I
1 I
protein I
kinase I
when O
coexpressed O
in O
vertebrate O
tissue O
culture O
cells O
. O

To O
determine O
the O
transactivation O
potential O
of O
each O
of O
the O
four O
Ahr B
Sp1 B
sites I
, O
we O
fused O
the O
Ahr B
promoter I
to O
a O
luciferase B
( O
LUC B
) O
reporter O
gene O
and O
transfected O
the O
construct O
into O
the O
Drosophila O
cell O
line O
Schneider O
- O
2 O
, O
which O
contains O
no O
Sp1 B
or O
Sp1 B
- I
like I
factors I
. O

We O
determined O
that O
Hop B
( I
T42 I
) I
contains O
a O
glutamic O
acid O
- O
to O
- O
lysine O
substitution O
at O
amino O
acid O
residue O
695 O
( O
E695K O
) O
. O

LAC9 B
is O
a O
DNA O
- O
binding O
protein O
that O
regulates O
transcription O
of O
the O
lactose B
- I
galactose I
regulon I
in O
Kluyveromyces O
lactis O
. O

The O
vertebrate B
transcription I
factors I
TCF I
( O
T B
cell I
factor I
) O
and O
LEF B
( O
lymphocyte B
enhancer I
binding I
factor I
) O
interact O
with O
beta B
- I
catenin I
and O
are O
hypothesized O
to O
mediate O
Wingless B
/ O
Wnt B
signaling O
. O

The O
vertebrate B
transcription I
factors I
TCF I
( O
T B
cell I
factor I
) O
and O
LEF B
( O
lymphocyte B
enhancer I
binding I
factor I
) O
interact O
with O
beta B
- I
catenin I
and O
are O
hypothesized O
to O
mediate O
Wingless B
/ O
Wnt B
signaling O
. O

Mouse B
GRK6 I
- I
C I
displays O
none O
of O
these O
motifs O
. O

Plasmid O
subclones O
of O
recombinant O
phage O
lambda O
Asm152 O
were O
able O
to O
complement O
both O
Escherichia B
coli I
gltB I
and O
A O
. O
sesbaniae O
Asm O
- O
Vi O
mutants O
; O
NADPH B
- I
glutamate I
synthase I
activity O
was O
detected O
in O
all O
such O
strains O
complemented O
to O
Asm O
+ O
. O

Eleven O
of O
the O
12 O
exons O
have O
complete O
sequence O
homology O
with O
the O
RBM B
- I
1 I
sequence I
. O

For O
the O
first O
time O
also O
a O
genomic O
sequence O
for O
a O
red B
algal I
lhc I
gene I
is O
presented O
. O

In O
vitro O
, O
c B
- I
Src I
phosphorylated O
FAK B
Tyr I
- I
925 I
in O
a O
glutathione B
S I
- I
transferase I
- O
FAK B
C O
- O
terminal O
domain O
fusion O
protein O
, O
whereas O
FAK O
did O
not O
. O

In O
vitro O
, O
c B
- I
Src I
phosphorylated O
FAK B
Tyr I
- I
925 I
in O
a O
glutathione B
S I
- I
transferase I
- O
FAK B
C O
- O
terminal O
domain O
fusion O
protein O
, O
whereas O
FAK O
did O
not O
. O

Gel O
shift O
analysis O
of O
protein O
binding O
from O
nuclear O
extracts O
to O
these O
caveolin B
promoter I
DNA I
sequences I
, O
together O
with O
DNase B
I I
footprinting O
, O
confirmed O
nucleoprotein O
binding O
to O
the O
SRE O
- O
like O
elements O
as O
part O
of O
the O
transcriptional O
response O
to O
LDL B
- I
FC I
. O

Initial O
computer O
based O
similarity O
searches O
identified O
human B
retinoblastoma I
binding I
protein I
1 I
( O
RBP B
- I
1 I
) O
, O
Drosophila B
melanogaster I
male I
specific I
lethal I
- I
3 I
( O
Msl B
- I
3 I
) O
, O
S B
. I
pombe I
altered I
polarity I
- I
13 I
( O
Alp13 B
) O
and O
S B
. I
cerevisiae I
Eaf3p I
, O
a O
component O
of O
the O
yeast B
NuA4 I
HAT B
complex O
( O
Galarneau O
et O
al O
. O
, O
2000 O
. O

The O
other O
regions O
include O
potential O
binding O
sites O
for O
transcription O
factors O
ATF B
, O
NF1 B
, O
and O
a O
CCAAT B
- I
binding I
protein I
. O

As O
already O
available O
for O
the O
other O
known O
mammalian O
members O
of O
this O
enzyme O
family O
, O
we O
here O
define O
structural O
and O
functional O
features O
of O
human B
lymphoma I
proprotein I
convertase I
( O
LPC B
) O
. O

The O
results O
show O
that O
while O
a O
larger O
polypeptide O
substrate O
carrying O
the O
HD1 B
/ I
3C I
site I
was O
processed O
more O
efficiently O
than O
a O
polypeptide O
substrate O
carrying O
the O
POL B
/ I
Zn I
site I
, O
cleavage O
of O
the O
synthetic O
peptide O
substrates O
containing O
these O
two O
cleavage O
sites O
occurred O
at O
similar O
efficiencies O
. O

The O
results O
show O
that O
while O
a O
larger O
polypeptide O
substrate O
carrying O
the O
HD1 B
/ I
3C I
site I
was O
processed O
more O
efficiently O
than O
a O
polypeptide O
substrate O
carrying O
the O
POL B
/ I
Zn I
site I
, O
cleavage O
of O
the O
synthetic O
peptide O
substrates O
containing O
these O
two O
cleavage O
sites O
occurred O
at O
similar O
efficiencies O
. O

An O
ERp60 B
- I
like I
protein I
from O
the O
filarial O
parasite O
Dirofilaria O
immitis O
has O
both O
transglutaminase O
and O
protein O
disulfide O
isomerase O
activity O
. O

On O
Western O
blots O
, O
the O
same O
antibodies O
recognized O
the O
recombinant O
protein O
migrating O
slightly O
slower O
on O
SDS O
/ O
PAGE O
than O
chicken B
axonin I
- I
1 I
. O

We O
tested O
several O
growth O
regulatory O
genes O
that O
are O
repressed O
in O
senescent O
cells O
for O
ability O
to O
restore O
activity O
to O
T B
[ I
K1 I
] I
. O

In O
this O
study O
, O
we O
show O
that O
HNF B
- I
4 I
, O
a O
member O
of O
the O
steroid B
hormone I
receptor I
superfamily I
, O
binds O
the O
AF B
- I
1 I
site I
on O
the O
apoB B
promoter I
and O
through O
it O
activates O
transcription O
in O
transient O
transfection O
assays O
in O
both O
liver O
and O
non O
- O
liver O
cell O
lines O
, O
HepG2 O
and O
HeLa O
, O
respectively O
. O

In O
this O
study O
, O
we O
show O
that O
HNF B
- I
4 I
, O
a O
member O
of O
the O
steroid B
hormone I
receptor I
superfamily I
, O
binds O
the O
AF B
- I
1 I
site I
on O
the O
apoB B
promoter I
and O
through O
it O
activates O
transcription O
in O
transient O
transfection O
assays O
in O
both O
liver O
and O
non O
- O
liver O
cell O
lines O
, O
HepG2 O
and O
HeLa O
, O
respectively O
. O

Cloning O
the O
cDNA O
for O
a O
new O
human B
zinc I
finger I
protein I
defines O
a O
group O
of O
closely O
related O
Kruppel B
- I
like I
transcription I
factors I
. O

By O
computed O
homology O
search O
, O
we O
noticed O
significant O
similarities O
between O
US3 B
PK I
and O
p21 B
- I
activated I
kinase I
( O
PAK B
) O
, O
which O
is O
activated O
by O
the O
Cdc42 B
or O
Rac B
. O

The O
CHED B
protein I
includes O
the O
consensus O
ATP O
binding O
and O
phosphorylation O
domains O
characteristic O
of O
kinases O
, O
displays O
34 O
- O
42 O
% O
identically O
aligned O
amino O
acid O
residues O
with O
other O
cdc2 B
- I
related I
kinases I
, O
and O
is O
considerably O
longer O
at O
its O
amino O
and O
carboxyl O
termini O
. O

Antisense O
oligonucleotides O
complementary O
to O
the O
5 O
' O
end O
of O
PKC B
- I
zeta I
mRNA I
sequences I
significantly O
reduced O
the O
collagen B
lattice O
- O
stimulated O
alpha2 O
and O
MMP B
- I
1 I
mRNA I
levels O
. O

Residues O
crucial O
for O
Ras B
interaction O
with O
GDP B
- I
GTP I
exchangers I
. O

Two O
different O
genes O
( O
polA B
and O
polB B
) O
encoding O
family B
B I
DNA I
polymerases I
were O
cloned O
from O
the O
organism O
by O
PCR O
using O
degenerated O
primers O
based O
on O
the O
two O
conserved O
motifs O
( O
motif O
A O
and O
B O
) O
. O

Structure O
and O
regulation O
of O
the O
luteinizing B
hormone I
receptor I
gene I
. O

3 O
- O
5 O
- O
fold O
increases O
in O
EGF B
receptor I
but O
not O
p185 B
( O
neu B
) O
tyrosine O
phosphorylation O
occur O
following O
Gi B
- I
coupled I
receptor I
stimulation O
. O

Fusions O
between O
the O
GAL B
DNA I
binding I
domain I
and O
full B
- I
length I
mSin3 I
were O
also O
capable O
of O
repression O
. O

Fusions O
between O
the O
GAL B
DNA I
binding I
domain I
and O
full B
- I
length I
mSin3 I
were O
also O
capable O
of O
repression O
. O

The O
full O
- O
length O
cDNA O
was O
cloned O
and O
sequenced O
, O
and O
the O
inferred O
amino O
acid O
sequence O
was O
found O
to O
encode O
a O
novel O
protein O
, O
which O
we O
named O
cystatin B
M I
, O
with O
40 O
% O
homology O
to O
human B
family I
2 I
cystatins I
and O
similar O
overall O
structure O
. O

We O
have O
isolated O
a O
unique O
murine B
FLT3 I
cDNA I
that O
codes O
for O
a O
variant O
isoform O
of O
FLT3 B
, O
devoid O
of O
the O
fifth O
Ig B
- I
like I
domain I
, O
by O
comparison O
with O
the O
prototypic O
form O
. O

An O
analysis O
of O
the O
c B
- I
kit I
5 I
' I
flanking I
region I
using O
the O
bacterial B
chloramphenicol I
acetyltransferase I
gene I
( O
CAT B
assay O
) O
in O
human O
erythroleukemia O
HEL O
cells O
, O
which O
express O
the O
endogenous O
c B
- I
kit I
mRNA I
at O
high O
levels O
, O
showed O
that O
a O
region O
from O
- O
180 O
to O
- O
22 O
is O
important O
for O
the O
expression O
of O
the O
c B
- I
kit I
gene I
. O

An O
analysis O
of O
the O
c B
- I
kit I
5 I
' I
flanking I
region I
using O
the O
bacterial B
chloramphenicol I
acetyltransferase I
gene I
( O
CAT B
assay O
) O
in O
human O
erythroleukemia O
HEL O
cells O
, O
which O
express O
the O
endogenous O
c B
- I
kit I
mRNA I
at O
high O
levels O
, O
showed O
that O
a O
region O
from O
- O
180 O
to O
- O
22 O
is O
important O
for O
the O
expression O
of O
the O
c B
- I
kit I
gene I
. O

An O
analysis O
of O
the O
c B
- I
kit I
5 I
' I
flanking I
region I
using O
the O
bacterial B
chloramphenicol I
acetyltransferase I
gene I
( O
CAT B
assay O
) O
in O
human O
erythroleukemia O
HEL O
cells O
, O
which O
express O
the O
endogenous O
c B
- I
kit I
mRNA I
at O
high O
levels O
, O
showed O
that O
a O
region O
from O
- O
180 O
to O
- O
22 O
is O
important O
for O
the O
expression O
of O
the O
c B
- I
kit I
gene I
. O

The O
TCR B
beta I
enhancer I
was O
active O
on O
both O
the O
minimal B
simian I
virus I
40 I
promoter I
and O
a O
TCR B
beta I
variable I
gene I
promoter I
in O
both O
TCR B
alpha I
/ I
beta I
+ O
and O
TCR B
gamma I
/ I
delta I
+ O
T O
cells O
. O

The O
TCR B
beta I
enhancer I
was O
active O
on O
both O
the O
minimal B
simian I
virus I
40 I
promoter I
and O
a O
TCR B
beta I
variable I
gene I
promoter I
in O
both O
TCR B
alpha I
/ I
beta I
+ O
and O
TCR B
gamma I
/ I
delta I
+ O
T O
cells O
. O

Mean O
CD4 B
percentages O
were O
lower O
postpartum O
( O
21 O
. O
9 O
+ O
/ O
- O
3 O
. O
4 O
) O
than O
prepartum O
( O
45 O
. O
1 O
+ O
/ O
- O
6 O
. O
7 O
) O
in O
all O
five O
patients O
studied O
, O
although O
proliferative O
responses O
to O
the O
mitogens B
phytohemagglutinin I
and I
pokeweed I
were O
unchanged O
during O
the O
study O
period O
. O

In O
vitro O
, O
SHIP B
catalyzes O
the O
conversion O
of O
the O
phosphoinositide B
3 I
- I
kinase I
( O
PI3K B
) O
product O
phosphatidylinositol O
3 O
, O
4 O
, O
5 O
- O
trisphosphate O
( O
PIP3 O
) O
into O
phosphatidylinositol O
3 O
, O
4 O
- O
bisphosphate O
. O

Evidence O
that O
the O
AT1A B
receptor I
activates O
transcription B
factor I
- I
Stat91 I
and O
/ O
or O
a O
related O
protein O
. O

The O
transcriptional O
start O
site O
( O
s O
) O
of O
the O
IA B
- I
2 I
gene I
was O
mapped O
by O
5 O
' O
rapid O
amplification O
of O
cDNA O
ends O
to O
97 O
bp O
upstream O
of O
the O
translational O
start O
site O
. O

The O
RAG B
- I
2 I
gene I
encodes O
a O
component O
of O
the O
V B
( I
D I
) I
J I
recombinase I
which O
is O
essential O
for O
the O
assembly O
of O
antigen O
receptor O
genes O
in O
B O
and O
T O
lymphocytes O
. O

We O
have O
characterized O
21 O
mutations O
in O
the O
type B
VII I
collagen I
gene I
( O
COL7A1 B
) O
encoding O
the O
anchoring O
fibrils O
, O
18 O
of O
which O
were O
not O
previously O
reported O
, O
in O
patients O
from O
15 O
unrelated O
families O
with O
recessive O
dystrophic O
epidermolysis O
bullosa O
( O
RDEB O
) O
. O

Accordingly O
, O
constitutive O
downregulation O
of O
expression O
of O
accessory O
molecules O
of O
the O
MHC B
class I
I I
pathway I
can O
reveal O
differences O
between O
H2 B
class I
I I
alleles I
in O
antigen O
presentation O
not O
encountered O
when O
the O
expression O
levels O
are O
augmented O
. O

Accordingly O
, O
constitutive O
downregulation O
of O
expression O
of O
accessory O
molecules O
of O
the O
MHC B
class I
I I
pathway I
can O
reveal O
differences O
between O
H2 B
class I
I I
alleles I
in O
antigen O
presentation O
not O
encountered O
when O
the O
expression O
levels O
are O
augmented O
. O

We O
also O
demonstrate O
that O
a O
p110RB1 B
mutant I
, O
which O
is O
refractory O
to O
cell O
cycle O
phosphorylation O
but O
intact O
in O
E1a B
/ O
large B
T I
antigen I
- O
binding O
properties O
, O
represses O
EIIaE B
with O
50 O
- O
to O
80 O
- O
fold O
greater O
efficiency O
than O
wild B
- I
type I
p110RB1 I
. O

The O
IGFBP B
- I
1 I
IRS B
and O
PEPCK B
IRS B
both O
bind O
the O
alpha O
and O
beta O
forms O
of O
hepatic B
nuclear I
factor I
3 I
( O
HNF B
- I
3 I
) O
, O
although O
the O
latter O
does O
so O
with O
a O
sixfold O
- O
lower O
relative O
affinity O
. O

This O
cell O
line O
expresses O
productively O
rearranged O
immunoglobulin B
genes I
as O
well O
as O
the O
Oct B
- I
2 I
gene I
at O
high O
levels O
which O
are O
comparable O
to O
those O
observed O
in O
activated O
murine O
splenic O
B O
cells O
. O

To O
examine O
the O
biochemical O
mechanism O
of O
Tax1 B
transactivation O
, O
we O
have O
developed O
an O
in O
vitro O
transactivation O
assay O
in O
which O
wild O
- O
type O
Tax1 B
is O
able O
to O
specifically O
transactivate O
a O
polymerase B
II I
promoter O
through O
upstream O
Tax1 B
- I
responsive I
elements I
. O

Interestingly O
, O
PMA O
- O
, O
PDGF B
- O
, O
and O
serum O
- O
induced O
GHR B
proteolysis O
was O
associated O
with O
substantial O
decreases O
in O
GH B
- O
induced O
activation O
of O
Janus B
kinase I
- I
2 I
, O
which O
were O
also O
prevented O
by O
IC3 O
. O

Reactive O
mesothelial O
cells O
, O
usually O
seen O
as O
exfoliated O
cells O
, O
were O
consistently O
strongly O
positive O
for O
alpha B
1 I
- I
antichymotrypsin I
and O
more O
variably O
for O
alpha B
1 I
- I
antitrypsin I
and O
lysozyme B
. O

Reactive O
mesothelial O
cells O
, O
usually O
seen O
as O
exfoliated O
cells O
, O
were O
consistently O
strongly O
positive O
for O
alpha B
1 I
- I
antichymotrypsin I
and O
more O
variably O
for O
alpha B
1 I
- I
antitrypsin I
and O
lysozyme B
. O

We O
show O
that O
Fos B
down O
regulates O
several O
immediate B
- I
early I
genes I
( O
c B
- I
fos I
, O
Egr B
- I
1 I
, O
and O
Egr B
- I
2 I
) O
after O
mitogenic O
stimulation O
. O

Intrathecal O
injections O
of O
small O
volumes O
of O
the O
alpha B
2 I
- I
adrenoceptor I
agonists O
, O
xylazine O
and O
clonidine O
, O
into O
the O
cervical O
region O
of O
the O
spinal O
cord O
of O
conscious O
unrestrained O
sheep O
produced O
a O
dose O
- O
dependent O
analgesia O
of O
the O
forelimbs O
as O
measured O
using O
a O
mechanical O
pressure O
device O
. O

Second O
, O
CGGA O
- O
containing O
sequences O
placed O
at O
- O
88 O
in O
the O
delta B
MTV I
- I
CAT I
reporter I
plasmid O
conferred O
insulin B
responsiveness O
to O
the O
mammary B
tumor I
virus I
promoter I
. O

In O
the O
absence O
of O
c B
- I
fos I
gene I
expression O
, O
c B
- I
Fos I
protein I
appears O
to O
be O
replaced O
by O
proteins O
of O
Fos B
family I
( O
Fra B
- I
1 I
) O
and O
ATF B
family I
( O
ATF B
- I
2 I
and O
ATFa B
) O
. O

In O
the O
absence O
of O
c B
- I
fos I
gene I
expression O
, O
c B
- I
Fos I
protein I
appears O
to O
be O
replaced O
by O
proteins O
of O
Fos B
family I
( O
Fra B
- I
1 I
) O
and O
ATF B
family I
( O
ATF B
- I
2 I
and O
ATFa B
) O
. O

The O
dopamine B
D1 I
dopamine I
receptor I
antagonist O
SCH O
23390 O
dose O
dependently O
( O
7 O
. O
5 O
- O
30 O
micrograms O
/ O
kg O
s O
. O
c O
. O
) O
antagonized O
the O
stimulant O
locomotor O
effect O
on O
both O
drugs O
but O
did O
not O
prevent O
their O
antiimmobility O
effect O
on O
the O
behavioral O
despair O
test O
. O

Basic B
helix I
- I
loop I
- I
helix I
proteins I
can O
act O
at O
the O
E O
- O
box O
within O
the O
serum O
response O
element O
of O
the O
c B
- I
fos I
promoter I
to O
influence O
hormone O
- O
induced O
promoter O
activation O
in O
Sertoli O
cells O
. O

From O
this O
comparison O
of O
aa O
sequences O
, O
the O
ATPK7 B
protein I
is O
considered O
to O
be O
a O
member O
of O
a O
novel O
subfamily O
of O
Ser B
/ I
Thr I
PKs I
in O
plants O
. O

SATB1 B
interacted O
with O
CDP B
through O
its O
DNA O
- O
binding O
domain O
, O
as O
demonstrated O
by O
glutathione B
S I
- I
transferase I
( O
GST B
) O
pull O
- O
down O
assays O
. O

This O
cDNA O
corresponded O
to O
FGF B
- I
binding I
protein I
( O
FGF B
- I
BP I
) O
, O
a O
secreted O
protein O
previously O
shown O
to O
bind O
acidic O
and O
basic B
FGF I
and O
to O
modulate O
their O
activities O
. O

The O
three O
OAS B
genes I
are O
flanked O
by O
markers B
WI I
- I
10614 I
( O
cen B
) O
and O
D12S2293 B
( O
tel B
) O
and O
are O
contained O
within O
three O
sets O
of O
overlapping O
cosmid O
clones O
. O

However O
, O
both O
peptides O
1 O
- O
49 O
and O
63 O
- O
87 O
bound O
to O
PDE B
alpha I
/ I
beta I
in O
a O
solid O
- O
phase O
binding O
assay O
. O

The O
mutation O
also O
preferentially O
limits O
( O
compared O
with O
total O
protein O
synthesis O
) O
translation O
of O
an O
induced O
gene O
that O
depends O
on O
five O
AGA O
codons O
, O
i O
. O
e O
. O
, O
the O
lambda B
cI I
repressor I
gene I
. O

Five O
RNA O
transcripts O
of O
about O
1 O
. O
2 O
to O
1 O
. O
7 O
kilobases O
were O
mapped O
to O
a O
part O
of O
the O
genome O
of O
insect O
iridescent O
virus O
type O
6 O
( O
Chilo O
iridescent O
virus O
; O
CIV O
) O
between O
genome O
coordinates O
0 O
. O
832 O
and O
0 O
. O
856 O
within O
the O
EcoRI B
DNA I
fragment I
F I
. O

The O
NF B
- I
kappa I
B I
precursor O
p100 B
( O
lyt B
- I
10 I
, O
p97 B
, O
p98 B
) O
generates O
after O
proteolytic O
processing O
a O
52 O
kDa O
subunit O
, O
which O
can O
bind O
to O
kappa B
B I
- I
motifs I
. O

The O
NF B
- I
kappa I
B I
precursor O
p100 B
( O
lyt B
- I
10 I
, O
p97 B
, O
p98 B
) O
generates O
after O
proteolytic O
processing O
a O
52 O
kDa O
subunit O
, O
which O
can O
bind O
to O
kappa B
B I
- I
motifs I
. O

We O
conclude O
from O
these O
observations O
that O
the O
cTnC B
3 I
' I
Ile I
element I
is O
a O
composite O
enhancer O
that O
functions O
through O
the O
combined O
interactions O
of O
at O
least O
five O
regulatory O
elements O
and O
their O
cognate O
binding O
factors O
: O
three O
or O
four O
E O
- O
boxes O
, O
a O
MEF B
- I
2 I
site I
, O
and O
a O
MEF B
- I
3 I
site I
. O

We O
conclude O
from O
these O
observations O
that O
the O
cTnC B
3 I
' I
Ile I
element I
is O
a O
composite O
enhancer O
that O
functions O
through O
the O
combined O
interactions O
of O
at O
least O
five O
regulatory O
elements O
and O
their O
cognate O
binding O
factors O
: O
three O
or O
four O
E O
- O
boxes O
, O
a O
MEF B
- I
2 I
site I
, O
and O
a O
MEF B
- I
3 I
site I
. O

These O
data O
show O
that O
the O
processing O
of O
specific O
target O
transcripts O
, O
such O
as O
the O
P B
- I
element I
mRNA I
, O
is O
regulated O
by O
a O
functional O
PSI B
- O
U1 B
snRNP O
interaction O
in O
Drosophila O
. O

Urease B
activity O
, O
judged O
as O
the O
amount O
of O
ammonia O
production O
from O
urea O
, O
could O
be O
measured O
at O
25 O
ng O
per O
tube O
( O
S O
/ O
N O
= O
1 O
. O
5 O
) O
with O
Jack B
bean I
meal I
urease I
. O

Dynamic O
expression O
of O
broad B
- I
complex I
isoforms I
mediates O
temporal O
control O
of O
an O
ecdysteroid O
target O
gene O
at O
the O
onset O
of O
Drosophila O
metamorphosis O
. O

This O
mutant O
also O
functions O
in O
vivo O
as O
a O
trans O
- O
acting O
dominant O
negative O
regulator O
: O
the O
transcriptional O
inducibility O
of O
the O
HIV B
long I
terminal I
repeat I
( O
which O
contains O
two O
potential O
NF B
- I
kappa I
B I
binding I
sites I
) O
by O
phorbol O
ester O
( O
PMA O
) O
is O
inhibited O
when O
it O
is O
co O
- O
transfected O
into O
CD4 B
+ I
T O
cells O
with O
the O
delta O
SP O
mutant O
. O

Moreover O
, O
such O
mutations O
lead O
to O
a O
dramatic O
transition O
in O
chromatin O
structure O
: O
the O
DNase B
I I
hypersensitive I
region I
is O
replaced O
by O
two O
stable O
, O
sequence O
- O
positioned O
nucleosomes O
. O

However O
, O
coligation O
of O
Fc B
gamma I
RIIB1 I
with O
B B
cell I
Ag I
receptors I
( O
BCR B
) O
inhibits O
BCR B
- O
mediated O
signaling O
by O
a O
mechanism O
that O
may O
involve O
recruitment O
of O
phosphatases B
SHP I
- I
1 I
, O
SHP B
- I
2 I
, O
and O
the O
SH2 B
containing I
inositol I
5 I
' I
phosphatase I
( O
SHIP B
) O
to O
the O
phosphorylated O
Fc B
gamma I
RIIB1 I
immunoreceptor I
tyrosine I
- I
based I
inhibitory I
motif I
. O

However O
, O
coligation O
of O
Fc B
gamma I
RIIB1 I
with O
B B
cell I
Ag I
receptors I
( O
BCR B
) O
inhibits O
BCR B
- O
mediated O
signaling O
by O
a O
mechanism O
that O
may O
involve O
recruitment O
of O
phosphatases B
SHP I
- I
1 I
, O
SHP B
- I
2 I
, O
and O
the O
SH2 B
containing I
inositol I
5 I
' I
phosphatase I
( O
SHIP B
) O
to O
the O
phosphorylated O
Fc B
gamma I
RIIB1 I
immunoreceptor I
tyrosine I
- I
based I
inhibitory I
motif I
. O

Transient O
cotransfection O
analyses O
indicate O
that O
the O
cooperative O
association O
of O
NF B
- I
IL I
- I
6 I
and O
RelA B
with O
the O
IL B
- I
8 I
promoter I
results O
in O
synergistic O
transcriptional O
activation O
. O

Cotransfection O
of O
pINV O
- O
2473 O
, O
a O
construct O
containing O
2473 O
base O
pairs O
of O
hINV B
upstream I
sequence I
linked O
to O
luciferase B
, O
with O
POU B
homeodomain I
transcription I
factors I
Oct1 B
, O
Oct2 B
, O
Brn4 B
, O
SCIP B
, O
Skn1a B
or O
Skn1i B
, O
results O
in O
a O
strong O
suppression O
of O
basal O
promoter O
activity O
. O

We O
have O
compared O
the O
ability O
of O
GST B
- O
Bem3 B
to O
serve O
as O
a O
GAP B
for O
Cdc42Hs B
relative O
to O
other O
members O
of O
the O
rho B
- O
GAP B
subfamily O
and O
found O
the O
following O
order O
of O
potency O
: O
human B
platelet I
Cdc42Hs I
GAP I
> O
p190 B
> O
Bem3 B
> O
break B
point I
cluster I
region I
protein I
, O
whereas O
p85 B
, O
like O
Bem2 B
, O
shows O
no O
GAP B
activity O
or O
any O
ability O
to O
bind O
to O
the O
GTP O
- O
bound O
form O
of O
Cdc42Hs B
. O

Ligand O
binding O
of O
multi O
- O
chain O
antigen O
receptors O
and O
hematopoietin B
/ O
cytokine O
receptors O
results O
in O
rapid O
activation O
of O
protein B
tyrosine I
kinase I
( O
PTK B
) O
- O
dependent O
signalling O
molecules O
such O
as O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

Ligand O
binding O
of O
multi O
- O
chain O
antigen O
receptors O
and O
hematopoietin B
/ O
cytokine O
receptors O
results O
in O
rapid O
activation O
of O
protein B
tyrosine I
kinase I
( O
PTK B
) O
- O
dependent O
signalling O
molecules O
such O
as O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

Peptide O
competition O
studies O
have O
localized O
a O
cyclin B
A I
interaction I
site I
to O
a O
Lys381Lys382Leu383Met384Phe385 O
sequence O
within O
C O
- O
terminal O
negative O
regulatory O
domain O
of O
human B
p53 I
. O

Two O
putative O
ATP O
- O
binding O
domains O
were O
identified O
, O
one O
in O
the O
amino O
- O
terminal O
half O
of O
the O
argA B
- I
encoded I
protein I
and O
the O
other O
in O
the O
carboxy O
- O
terminal O
half O
. O

Biochemical O
studies O
and O
studies O
of O
cells O
expressing O
mutant O
IL B
- I
2 I
receptors I
indicate O
that O
IL B
- I
2 I
- O
induced O
tyrosine B
kinase I
activation O
initiates O
a O
complex O
signaling O
cascade O
. O

Cloning O
of O
the O
GATA B
- I
binding I
protein I
that O
regulates O
endothelin B
- I
1 I
gene I
expression O
in O
endothelial O
cells O
. O

Cloning O
of O
the O
GATA B
- I
binding I
protein I
that O
regulates O
endothelin B
- I
1 I
gene I
expression O
in O
endothelial O
cells O
. O

The O
BHV B
- I
1 I
UL24 I
, O
UL25 B
, O
UL26 B
and O
UL26 B
. I
5 I
transcripts I
all O
terminated O
at O
a O
common O
3 O
' O
- O
polyadenylation O
site O
and O
varied O
significantly O
in O
their O
relative O
abundance O
. O

The O
BHV B
- I
1 I
UL24 I
, O
UL25 B
, O
UL26 B
and O
UL26 B
. I
5 I
transcripts I
all O
terminated O
at O
a O
common O
3 O
' O
- O
polyadenylation O
site O
and O
varied O
significantly O
in O
their O
relative O
abundance O
. O

Electrophoretic O
mobility O
shift O
analysis O
of O
protein O
- O
DNA O
complexes O
formed O
with O
nuclear O
proteins O
isolated O
from O
I3C O
- O
treated O
and O
- O
untreated O
cells O
, O
in O
combination O
with O
supershift O
assays O
using O
Sp1 B
antibodies I
, O
demonstrated O
that O
the O
Sp1 B
- I
binding I
site I
in O
the O
CDK6 B
promoter I
forms O
a O
specific O
I3C O
- O
responsive O
DNA O
- O
protein O
complex O
that O
contains O
the O
Sp1 B
transcription I
factor I
. O

Low O
- O
affinity O
E2 B
- I
binding I
site I
mediates O
downmodulation O
of O
E2 B
transactivation O
of O
the O
human B
papillomavirus I
type I
8 I
late I
promoter I
. O

Untransformed O
3T3 O
cells O
carry O
abundant O
1 O
. O
9 O
kb O
Hox B
1 I
. I
3 I
RNA O
, O
whereas O
the O
methylcholanthrene O
- O
transformed O
MB66 O
and O
LTK O
- O
cells O
or O
3T3 O
cells O
transformed O
by O
the O
oncogenes O
src B
, O
fos B
or O
SV40 B
T I
antigen I
express O
only O
low O
levels O
. O

One O
of O
these O
clones O
encodes O
Xenopus B
N I
- I
ras I
. O

The O
median O
levels O
of O
t B
- I
PA I
Ag I
and O
PAI B
in O
plasma O
were O
respectively O
10 O
. O
7 O
ng O
/ O
ml O
( O
interquartile O
range O
8 O
. O
6 O
ng O
/ O
ml O
) O
and O
15 O
. O
7 O
IU O
/ O
ml O
( O
interquartile O
range O
12 O
. O
2 O
IU O
/ O
ml O
) O
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
BSMV B
coat I
protein I
is O
the O
sole O
translation O
product O
of O
the O
genomic B
RNA I
beta I
, O
whereas O
sgRNA B
beta I
1 I
serves O
as O
a O
messenger O
for O
translation O
of O
the O
beta B
b I
protein I
, O
and O
sgRNA B
beta I
2 I
functions O
as O
a O
messenger O
for O
translation O
of O
beta B
c I
and O
beta B
d I
and O
the O
newly O
discovered O
beta B
d I
' I
protein I
. O

When O
the O
measured O
beta B
- I
galactosidase I
activity O
in O
the O
pWP O
- O
transfected O
cells O
was O
normalized O
to O
the O
pCH110 O
- O
transfected O
cells O
( O
an O
appropriate O
control O
if O
the O
SV40 B
early I
region I
promoter I
functions O
constitutively O
in O
various O
cell O
lines O
) O
, O
the O
results O
suggested O
that O
the O
promoter O
region O
of O
the O
PLP B
gene I
contains O
the O
information O
necessary O
for O
initiation O
of O
transcription O
in O
a O
C6 O
cell O
- O
specific O
manner O
. O

There O
is O
an O
overall O
functional O
similarity O
between O
IL B
- I
6 I
and O
c B
- I
fos I
promoters I
, O
since O
transfection O
of O
excess O
amounts O
of O
either O
promoter O
DNA O
into O
intact O
HeLa O
cells O
modulates O
the O
function O
of O
the O
heterologous O
promoter O
construct O
. O

We O
suggest O
that O
this O
relatively O
small O
deletion O
affects O
a O
segment O
containing O
3 B
' I
VH I
genes I
with O
important O
regulatory O
functions O
, O
the O
loss O
of O
which O
leads O
to O
the O
ali O
phenotype O
. O

Two O
SH2 B
domains I
of O
p120 B
Ras B
GTPase B
- I
activating I
protein I
bind O
synergistically O
to O
tyrosine O
phosphorylated O
p190 B
Rho O
GTPase B
- I
activating I
protein I
. O

Two O
SH2 B
domains I
of O
p120 B
Ras B
GTPase B
- I
activating I
protein I
bind O
synergistically O
to O
tyrosine O
phosphorylated O
p190 B
Rho O
GTPase B
- I
activating I
protein I
. O

p120 B
GTPase B
- I
activating I
protein I
( O
GAP B
) O
is O
a O
negative O
regulator O
of O
Ras B
that O
functions O
at O
a O
key O
relay O
point O
in O
signal O
transduction O
pathways O
that O
control O
cell O
proliferation O
. O

Here O
we O
report O
the O
cloning O
of O
the O
hemF B
gene I
, O
encoding O
the O
aerobic O
coproporphyrinogen B
III I
oxidase I
from I
Escherichia I
coli I
, O
by O
functional O
complementation O
of O
a O
Saccharomyces B
cerevisiae I
HEM13 I
mutant I
. O

We O
recently O
reported O
the O
cloning O
and O
sequencing O
of O
the O
alpha B
7 I
integrin I
chain I
and O
its O
regulated O
expression O
during O
the O
development O
of O
skeletal O
muscle O
( O
Song O
et O
al O
. O

NF B
- I
kappaB I
DNA O
- O
protein O
binding O
and O
ICAM B
- I
1 I
promoter I
activity O
were O
enhanced O
by O
IL B
- I
1beta I
and O
these O
effects O
were O
inhibited O
by O
tyrphostin O
23 O
, O
but O
not O
by O
PD O
98059 O
or O
SB O
203580 O
. O

Using O
the O
two O
- O
hybrid O
screening O
method O
, O
we O
have O
identified O
an O
additional O
component O
of O
the O
CCAAT B
- I
binding I
factor I
. O

The O
myb B
proto I
oncogene I
product I
( O
c B
- I
Myb I
) O
is O
a O
transcriptional O
regulator O
and O
its O
expression O
and O
function O
are O
tightly O
linked O
to O
the O
cellular O
entry O
into O
S O
phase O
and O
DNA O
synthesis O
. O

To O
better O
understand O
the O
relationship O
between O
expression O
of O
an O
oncogene O
and O
genetic O
instability O
, O
we O
have O
studied O
a O
cell O
line O
expressing O
an O
activated B
human I
Ha I
- I
ras I
under O
the O
control O
of O
bacterial B
lactose I
operon I
regulatory I
elements I
for O
changes O
in O
methotrexate O
resistance O
and O
dihydrofolate B
reductase I
( O
dhfr B
) O
gene O
amplification O
following O
mutant B
Ha I
- I
ras I
induction O
. O

Mammalian O
homologues O
of O
the O
Polycomb B
- I
group I
gene I
Enhancer B
of I
zeste I
mediate O
gene O
silencing O
in O
Drosophila O
heterochromatin O
and O
at O
S O
. O
cerevisiae O
telomeres O
. O

The O
results O
obtained O
with O
[ B
F304 I
] I
R2 I
indicate O
that O
structural O
changes O
in O
E B
. I
coli I
R2 I
in O
the O
vicinity O
of O
this O
helix O
distortion O
can O
influence O
the O
catalytic O
activity O
of O
the O
holoenzyme O
. O

The O
results O
obtained O
with O
[ B
F304 I
] I
R2 I
indicate O
that O
structural O
changes O
in O
E B
. I
coli I
R2 I
in O
the O
vicinity O
of O
this O
helix O
distortion O
can O
influence O
the O
catalytic O
activity O
of O
the O
holoenzyme O
. O

The O
LT B
- I
beta I
gene I
is O
expressed O
in O
lymphoid O
cells O
and O
organs O
, O
but O
little O
is O
known O
about O
its O
inducible O
regulation O
. O

Identification O
of O
an O
osteocalcin B
gene I
promoter I
sequence I
that O
binds O
AP1 B
. O

Expression O
of O
these O
chemokines O
is O
similar O
in O
that O
both O
require O
the O
NF B
- I
kappa I
B I
element I
and O
additional O
regions O
such O
as O
the O
CAAT B
/ I
enhancer I
binding I
protein I
( O
C B
/ I
EBP I
) O
element O
of O
the O
IL B
- I
8 I
promoter I
. O

The O
AP B
- I
1 I
recruited O
by O
ARF1 B
. I
GTP I
is O
released O
from O
the O
Golgi O
membrane O
by O
treatment O
with O
1 O
M O
Tris O
- O
HCl O
( O
pH O
7 O
) O
or O
upon O
reincubation O
at O
37 O
degreesC O
, O
whereas O
AP B
- I
1 I
recruited O
with O
GTPgammaS O
or O
by O
a O
constitutively O
active O
point O
mutant O
, O
ARF1 B
( I
Q71L I
) I
, O
remains O
membrane O
bound O
after O
either O
treatment O
. O

We O
found O
remarkable O
differences O
in O
the O
expression O
patterns O
of O
MTB B
- I
Zf I
mRNA I
and O
two O
other O
hybridizable O
mRNAs O
of O
5kb O
and O
8 O
. O
5 O
kb O
when O
human O
brain O
and O
primary O
brain O
tumors O
were O
compared O
. O

Temporal O
recruitment O
of O
the O
mSin3A B
- O
histone B
deacetylase I
corepressor O
complex O
to O
the O
ETS B
domain I
transcription I
factor I
Elk B
- I
1 I
. O

In O
addition O
, O
FOP B
- O
FGFR1 B
- O
expressing O
cells O
show O
constitutive O
phosphorylation O
of O
the O
positive O
regulator O
of O
translation O
p70S6 B
kinase I
; O
this O
phosphorylation O
is O
inhibited O
by O
PI3 B
- I
kinase I
and O
mTOR B
( O
mammalian B
target I
of I
rapamycin I
) O
inhibitors O
. O

The O
newly O
identified O
repressor O
element O
is O
a O
rare O
example O
of O
a O
naturally O
occurring O
perfect O
palindromic O
binding O
motif O
for O
the O
NF B
- I
kappa I
B I
/ O
Rel B
family O
of O
transcription O
factors O
. O

Murine B
ELAM I
- I
1 I
is O
encoded O
by O
a O
single O
- O
copy O
gene O
, O
spanning O
about O
13 O
kb O
, O
which O
is O
structurally O
organized O
into O
14 O
exons O
and O
13 O
introns O
; O
very O
similar O
to O
that O
of O
its O
human O
counterpart O
. O

We O
cloned O
the O
BamHI B
- I
F I
fragment I
from O
the O
left O
end O
of O
Ad4 O
in O
pUC13 O
- O
1 O
between O
the O
SalI B
and O
BamHI B
sites I
in O
order O
to O
carry O
out O
the O
structural O
analysis O
of O
the O
E1A B
region I
of I
Ad4 I
. O

We O
cloned O
the O
BamHI B
- I
F I
fragment I
from O
the O
left O
end O
of O
Ad4 O
in O
pUC13 O
- O
1 O
between O
the O
SalI B
and O
BamHI B
sites I
in O
order O
to O
carry O
out O
the O
structural O
analysis O
of O
the O
E1A B
region I
of I
Ad4 I
. O

The O
organization O
of O
the O
MBP B
- I
A I
gene I
is O
very O
similar O
to O
the O
arrangement O
of O
the O
gene O
encoding O
the O
highly O
homologous B
pulmonary I
surfactant I
apoprotein I
, O
although O
one O
of O
the O
intron O
positions O
is O
shifted O
by O
a O
single O
amino O
acid O
. O

The O
organization O
of O
the O
MBP B
- I
A I
gene I
is O
very O
similar O
to O
the O
arrangement O
of O
the O
gene O
encoding O
the O
highly O
homologous B
pulmonary I
surfactant I
apoprotein I
, O
although O
one O
of O
the O
intron O
positions O
is O
shifted O
by O
a O
single O
amino O
acid O
. O

Arg O
- O
130 O
, O
Gly O
- O
132 O
and O
Lys O
- O
167 O
are O
conserved O
in O
all O
members O
of O
the O
type B
IB I
topoisomerase I
family I
. O

Prevalence O
of O
use O
, O
claims O
volume O
, O
and O
expenditures O
were O
compared O
for O
cisapride O
, O
proton O
pump O
inhibitors O
, O
histamine B
- I
2 I
receptor I
antagonists O
, O
and O
the O
prokinetic O
agent O
metoclopramide O
during O
these O
periods O
. O

Using O
the O
conflict O
drinking O
test O
as O
a O
model O
, O
we O
studied O
in O
rats O
the O
effect O
of O
the O
nonselective O
beta B
- I
adrenoceptor I
blockers O
pindolol O
and O
cyanopindolol O
which O
bind O
to O
5 B
- I
HT1A I
and I
5 I
- I
HT1B I
receptors I
, O
and O
of O
the O
selective O
beta B
1 I
- I
and I
beta I
2 I
- I
adrenoceptor I
antagonists O
betaxolol O
and O
ICI O
118 O
, O
551 O
, O
respectively O
, O
which O
have O
a O
negligible O
affinity O
for O
5 B
- I
HT I
receptors I
. O

But O
if O
one O
equalizes O
the O
upper O
limits O
of O
normal O
for O
both O
markers O
to O
a O
common O
95 O
% O
specificity O
, O
the O
tumour O
- O
indicating O
sensitivity O
of O
CA B
19 I
- I
9 I
clearly O
surpasses O
that O
of O
CA B
50 I
. O

The O
uap100 B
cis O
- O
acting O
, O
up O
- O
promoter O
, O
constitutive O
mutation O
is O
a O
duplication O
that O
comprises O
two O
GATA O
sites O
and O
suppresses O
weakly O
the O
AREA B
zinc I
finger I
mutation I
but O
does O
not O
alleviate O
the O
need O
for O
functional O
UAY B
and O
AREA B
proteins I
. O

Cloning O
and O
sequence O
analysis O
of O
a O
chymotrypsinlike B
protease I
from I
Treponema I
denticola O
. O

The O
MAP B
kinase I
kinase I
kinase I
MLK2 B
co O
- O
localizes O
with O
activated O
JNK B
along O
microtubules O
and O
associates O
with O
kinesin B
superfamily I
motor O
KIF3 B
. O

An O
in O
vitro O
Raf B
- I
1 I
kinase I
assay O
, O
however O
, O
failed O
to O
detect O
LPS O
- O
induced O
Raf B
- I
1 I
kinase I
activity O
in O
RAW O
264 O
. O
7 O
cells O
, O
suggesting O
that O
in O
RAW O
264 O
. O
7 O
cells O
, O
Raf B
- I
1 I
kinase I
is O
not O
an O
activating O
component O
of O
the O
LPS O
signaling O
pathway O
regulating O
MAPK B
activity O
or O
sIL B
- I
1Ra I
promoter I
activity O
. O

An O
in O
vitro O
Raf B
- I
1 I
kinase I
assay O
, O
however O
, O
failed O
to O
detect O
LPS O
- O
induced O
Raf B
- I
1 I
kinase I
activity O
in O
RAW O
264 O
. O
7 O
cells O
, O
suggesting O
that O
in O
RAW O
264 O
. O
7 O
cells O
, O
Raf B
- I
1 I
kinase I
is O
not O
an O
activating O
component O
of O
the O
LPS O
signaling O
pathway O
regulating O
MAPK B
activity O
or O
sIL B
- I
1Ra I
promoter I
activity O
. O

An O
in O
vitro O
Raf B
- I
1 I
kinase I
assay O
, O
however O
, O
failed O
to O
detect O
LPS O
- O
induced O
Raf B
- I
1 I
kinase I
activity O
in O
RAW O
264 O
. O
7 O
cells O
, O
suggesting O
that O
in O
RAW O
264 O
. O
7 O
cells O
, O
Raf B
- I
1 I
kinase I
is O
not O
an O
activating O
component O
of O
the O
LPS O
signaling O
pathway O
regulating O
MAPK B
activity O
or O
sIL B
- I
1Ra I
promoter I
activity O
. O

An O
in O
vitro O
Raf B
- I
1 I
kinase I
assay O
, O
however O
, O
failed O
to O
detect O
LPS O
- O
induced O
Raf B
- I
1 I
kinase I
activity O
in O
RAW O
264 O
. O
7 O
cells O
, O
suggesting O
that O
in O
RAW O
264 O
. O
7 O
cells O
, O
Raf B
- I
1 I
kinase I
is O
not O
an O
activating O
component O
of O
the O
LPS O
signaling O
pathway O
regulating O
MAPK B
activity O
or O
sIL B
- I
1Ra I
promoter I
activity O
. O

Phosphorylation O
of O
the O
ras B
GTPase B
- I
activating I
protein I
( O
GAP B
) O
by O
the O
p93c B
- I
fes I
protein B
- I
tyrosine I
kinase I
in O
vitro O
and O
formation O
of O
GAP B
- O
fes B
complexes O
via O
an O
SH2 B
domain O
- O
dependent O
mechanism O
. O

Phosphorylation O
of O
the O
ras B
GTPase B
- I
activating I
protein I
( O
GAP B
) O
by O
the O
p93c B
- I
fes I
protein B
- I
tyrosine I
kinase I
in O
vitro O
and O
formation O
of O
GAP B
- O
fes B
complexes O
via O
an O
SH2 B
domain O
- O
dependent O
mechanism O
. O

The O
Htf9 B
- I
a I
gene I
encodes O
the O
RanBP1 B
protein I
, O
a O
major O
partner O
of O
the O
Ran B
GTPase I
. O

Our O
studies O
suggest O
that O
the O
helicase B
assembly O
protein O
is O
responsible O
for O
loading O
T4 B
gene I
41 I
helicase I
specifically O
at O
replication O
forks O
, O
and O
that O
its O
binding O
sites O
for O
each O
arm O
must O
hold O
more O
than O
six O
, O
but O
not O
more O
than O
12 O
nucleotides O
. O

The O
human B
SHBG I
proximal I
promoter I
was O
analyzed O
by O
DNase B
I I
footprinting O
, O
and O
the O
functional O
significance O
of O
6 O
footprinted O
regions O
( O
FP1 O
- O
FP6 O
) O
within O
the O
proximal O
promoter O
was O
studied O
in O
human O
HepG2 O
hepatoblastoma O
cells O
. O

Electrophoretic O
mobility O
- O
shift O
assays O
with O
nuclear O
extracts O
from O
COS O
- O
1 O
cells O
transfected O
with O
expression O
vectors O
for O
SMADs B
1 I
- I
5 I
indicate O
that O
SMAD3 B
forms O
a O
complex O
with O
a O
migration O
similar O
to O
that O
of O
the O
endogenous B
TGF I
- I
beta I
- I
specific I
complex I
observed O
in O
fibroblast O
extracts O
. O

The O
newly O
identified O
NF B
kappa I
B I
enhancer I
( O
TGGAAATTCC O
) O
is O
bound O
by O
a O
TNF B
alpha I
- O
induced O
nuclear O
protein O
and O
appears O
to O
be O
the O
key O
element O
in O
rapid O
transcription O
induction O
by O
TNF B
alpha I
( O
and O
TPA O
) O
, O
while O
transactivation O
of O
this O
element O
is O
repressed O
by O
the O
ligand O
- O
bound O
glucocorticoid B
receptor I
. O

In O
situ O
localization O
of O
PCP B
- I
A1 I
transcripts I
revealed O
that O
they O
accumulate O
specifically O
in O
pollen O
at O
the O
late O
binucleate O
/ O
trinucleate O
stage O
of O
development O
rather O
than O
in O
the O
tapetum O
, O
which O
previously O
was O
taken O
to O
be O
the O
principal O
source O
of O
the O
pollen O
coat O
. O

In O
vitro O
binding O
studies O
previously O
showed O
that O
NF B
- I
kappa I
B I
p50 B
homodimer O
binds O
the O
switch B
nuclear I
B I
- I
site I
protein I
( O
SNIP B
) O
of O
the O
S B
gamma I
3 I
tandem I
repeat I
. O

In O
this O
work O
, O
we O
determined O
the O
sequences O
of O
eight O
VirF B
- I
binding I
sites I
from O
four O
different O
genes O
, O
by O
DNase B
I I
or O
hydroxyl O
radical O
footprinting O
. O

One O
hundred O
cDNA O
clones O
were O
sequenced O
and O
8 O
RTKs B
were O
identified O
, O
as O
well O
as O
12 O
non O
- O
RTKs B
and O
2 O
serine B
/ I
threonine I
kinases I
. O

In O
EGF B
receptor I
- O
mediated O
signaling O
, O
the O
protein B
kinase I
PKB I
/ O
Akt B
and O
the O
mitogen B
- I
activated I
protein I
kinase I
c I
- I
Jun I
N I
- I
terminal I
kinase I
, O
but O
not O
extracellular B
signal I
- I
regulated I
kinase I
2 I
, O
function O
downstream O
of O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

In O
EGF B
receptor I
- O
mediated O
signaling O
, O
the O
protein B
kinase I
PKB I
/ O
Akt B
and O
the O
mitogen B
- I
activated I
protein I
kinase I
c I
- I
Jun I
N I
- I
terminal I
kinase I
, O
but O
not O
extracellular B
signal I
- I
regulated I
kinase I
2 I
, O
function O
downstream O
of O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

However O
, O
C B
/ I
EBP I
beta I
stimulated O
transcription O
primarily O
through O
the O
cAMP O
- O
responsive O
element O
( O
CRE O
) O
, O
which O
maps O
between O
positions O
- O
77 O
to O
- O
94 O
, O
but O
not O
at O
the O
more O
5 O
' O
- O
binding O
sites O
. O

cDNA O
cloning O
, O
sequencing O
and O
chromosome O
mapping O
of O
a O
non B
- I
erythroid I
spectrin I
, O
human B
alpha I
- I
fodrin I
. O

cDNA O
cloning O
, O
sequencing O
and O
chromosome O
mapping O
of O
a O
non B
- I
erythroid I
spectrin I
, O
human B
alpha I
- I
fodrin I
. O

To O
define O
the O
molecular O
mechanism O
regulating O
FGFR B
- I
1 I
gene I
expression O
in O
proliferating O
myoblasts O
and O
post O
- O
mitotic O
muscle O
fibers O
, O
we O
have O
isolated O
and O
partially O
characterized O
the O
avian O
FGFR B
- I
1 I
gene I
promoter O
. O

To O
define O
the O
molecular O
mechanism O
regulating O
FGFR B
- I
1 I
gene I
expression O
in O
proliferating O
myoblasts O
and O
post O
- O
mitotic O
muscle O
fibers O
, O
we O
have O
isolated O
and O
partially O
characterized O
the O
avian O
FGFR B
- I
1 I
gene I
promoter O
. O

These O
results O
demonstrate O
a O
specific O
association O
of O
SIV O
and O
HIV B
- I
2 I
nef I
, O
but O
not O
HIV B
- I
1 I
nef I
, O
with O
TCRzeta B
. O

These O
results O
demonstrate O
a O
specific O
association O
of O
SIV O
and O
HIV B
- I
2 I
nef I
, O
but O
not O
HIV B
- I
1 I
nef I
, O
with O
TCRzeta B
. O

Coexpression O
of O
CREB B
- I
binding I
protein I
( O
CBP B
) O
/ O
p300 B
with O
TReP B
- I
132 I
has O
an O
additive O
effect O
on O
promoter O
activity O
, O
and O
the O
proteins O
were O
demonstrated O
to O
interact O
physically O
. O

Carcinoma B
- I
related I
protein I
production O
may O
have O
played O
a O
role O
in O
the O
development O
of O
the O
observed O
renal O
lesions O
. O

The O
translated O
sequence O
of O
the O
FLI B
LRR I
associated I
protein I
( O
FLAP B
) O
encodes O
a O
novel O
protein O
not O
represented O
in O
the O
data O
base O
. O

Uptake O
of O
colicins B
required O
different O
domains O
in O
TonB B
, O
for O
colicin B
B I
and I
M I
around O
residue O
160 O
and O
for O
colicin B
Ia I
, O
a O
domain O
closer O
to O
the O
C O
- O
terminal O
end O
. O

Cells O
were O
cotransfected O
with O
this O
plasmid O
, O
and O
the O
appropriate O
responder O
plasmids O
and O
clonies O
were O
selected O
on O
the O
basis O
of O
their O
resistance O
to O
Geneticin O
( O
via O
the O
neomycin B
aminoglycoside I
phosphotransferase I
gene I
) O
. O

SCAN B
boxes O
are O
found O
in O
eight O
other O
genes O
in O
the O
GenBank O
database O
, O
five O
of O
which O
are O
also O
in O
the O
Kruppel B
family I
of O
zinc B
finger I
proteins I
lacking O
KRAB B
A I
and I
B I
domains O
and O
thereby O
define O
a O
new O
subclass O
of O
zinc B
finger I
proteins I
. O

Optimized O
USF B
and O
MYC B
DNA O
- O
binding O
sites O
, O
which O
differ O
in O
the O
nucleotides O
bordering O
the O
hexanucleotide O
box O
displace O
the O
E B
- I
C4 I
factor I
in O
competition O
assays O
but O
with O
lesser O
efficiency O
than O
the O
E B
- I
C4 I
site I
itself O
. O

Optimized O
USF B
and O
MYC B
DNA O
- O
binding O
sites O
, O
which O
differ O
in O
the O
nucleotides O
bordering O
the O
hexanucleotide O
box O
displace O
the O
E B
- I
C4 I
factor I
in O
competition O
assays O
but O
with O
lesser O
efficiency O
than O
the O
E B
- I
C4 I
site I
itself O
. O

TOM1 B
encodes O
a O
member O
of O
the O
hect B
- O
domain O
- O
containing O
E3 B
ubiquitin B
- I
protein I
ligase I
family O
that O
is O
required O
for O
growth O
at O
elevated O
temperatures O
. O

Genomic O
clones O
containing O
the O
C O
. O
briggsae O
gene O
are O
able O
to O
completely O
rescue O
the O
unc B
- I
119 I
phenotype I
in O
transgenic O
C O
. O
elegans O
mutants O
. O

Region O
- O
specific O
enhancers O
near O
two O
mammalian B
homeo I
box I
genes I
define O
adjacent O
rostrocaudal O
domains O
in O
the O
central O
nervous O
system O
. O

We O
suggest O
that O
the O
induction O
of O
IFNA B
promoter I
region I
requires O
cooperation O
between O
alpha B
F1 I
binding I
proteins I
and O
IRF B
- I
1 I
. O

Heterologous O
hybridization O
with O
a O
rps12 B
gene I
specific O
probe O
from O
Euglena O
has O
revealed O
the O
presence O
of O
rps12 B
homologous I
sequences I
within O
the O
inverted O
repeat O
of O
Spirodela O
chloroplast O
DNA O
on O
the O
fragment B
BamHI I
- I
V I
. O

These O
data O
also O
suggest O
the O
existence O
of O
a O
mechanism O
by O
which O
regulatory O
subunits O
modulate O
the O
PI B
3 I
- I
kinase I
- O
mediated O
signals O
, O
independent O
of O
the O
kinase O
activity O
, O
possibly O
through O
subcellular O
localization O
of O
the O
catalytic O
subunit O
or O
interaction O
with O
additional O
signaling O
molecules O
. O

Transfection O
of O
H B
chain I
loss I
variant I
myeloma O
with O
the O
complete O
12 O
kb O
construct O
, O
termed O
238H B
- I
Cmicro I
, O
resulted O
in O
secretion O
of O
intact O
Ig O
pairing O
238H B
- I
Cmicro I
, O
with O
a O
lambda B
L I
chain I
; O
however O
, O
transfectant B
Ig I
lacked O
autoreactivity O
and O
pathogenicity O
. O

The O
B B
. I
aphidicola I
argS I
- I
rrn I
DNA I
fragments I
from O
endosymbionts O
from O
seven O
species O
of O
aphids O
had O
promoter O
activities O
in O
E O
. O
coli O
which O
ranged O
from O
6 O
to O
135 O
% O
of O
that O
observed O
with O
a O
comparable O
DNA O
fragment O
of O
E B
. I
coli I
rrnB I
. O

MDA O
- O
MB O
- O
468 O
cells O
were O
stably O
transfected O
with O
either O
a O
plasmid O
having O
a O
CMV B
promoter I
- O
driven O
rabbit B
beta I
- I
globin I
gene I
or O
plasmids O
having O
a O
CMV B
promoter I
- O
driven O
chimeric O
gadd45 B
5 O
" O
- O
UTR O
- O
rabbit B
beta I
- I
globin I
gene O
, O
where O
the O
entire B
gadd45 I
5 I
" I
- I
UTR I
( I
from I
+ I
1 I
to I
+ I
298 I
) I
or O
a O
45 O
bp O
subfragment O
of O
the O
gadd45 B
5 I
" I
- I
UTR I
( I
from I
+ I
10 I
to I
+ I
55 I
) I
was O
positioned O
at O
the O
5 O
" O
- O
end O
of O

Activated O
FGFR3 B
predominantly O
interacts O
with O
GRB2 B
. I
Sos I
in O
complex O
with O
a O
previously O
identified O
90 O
- O
kDa O
protein O
and O
designated O
protein B
80K I
- I
H I
. O

Northern O
analyses O
further O
confirm O
that O
the O
expression O
of O
endogenous O
alpha B
- I
ENaC I
gene I
in O
salivary O
Pa O
- O
4 O
cells O
is O
suppressed O
by O
an O
ectopic O
HMGI B
- I
C I
overexpression O
. O

Removal O
of O
cyclin B
- I
dependant I
kinases I
( O
cdks B
) O
or O
cdk2 B
from O
these O
extracts O
using O
affinity O
matrices O
severely O
inhibits O
initiation O
of O
S O
phase O
. O

Following O
replicate O
control O
measurements O
, O
test O
ramps O
were O
repeated O
in O
the O
presence O
of O
sodium O
nitroprusside O
( O
1 O
microM O
) O
and O
phentolamine O
( O
1 O
microM O
) O
to O
eliminate O
potential O
smooth O
muscle O
and O
alpha B
1 I
- I
adrenoceptor I
effects O
, O
respectively O
. O

The O
DFGF B
- I
R I
protein I
may O
thus O
participate O
in O
receiving O
spatial O
cues O
that O
guide O
tracheal O
cell O
outgrowth O
. O

The O
NS B
- I
2 I
isoforms I
were O
resolved O
at O
a O
pI O
value O
close O
to O
5 O
. O
5 O
as O
three O
groups O
of O
unevenly O
phosphorylated O
polypeptides O
, O
each O
composed O
of O
at O
least O
two O
protein O
species O
. O

This O
interaction O
is O
functional O
as O
it O
leads O
to O
retargeting O
of O
NF B
- I
kappa I
B I
p50 B
from O
the O
nucleus O
to O
the O
cytoplasm O
. O

Rac2 B
, O
a O
member O
of O
the O
Rho B
family I
of O
GTPases B
, O
is O
highly O
expressed O
in O
myeloid O
cells O
and O
is O
a O
regulator O
of O
the O
NADPH B
- I
oxidase I
complex I
. O

This O
region O
shows O
46 O
% O
identity O
with O
the O
calmodulin B
- I
binding I
region I
of O
rat B
brain I
Ca2 I
+ I
/ I
calmodulin I
- I
dependent I
protein I
kinase I
II I
and O
32 O
% O
identity O
with O
the O
equivalent O
region O
of O
chicken B
smooth I
muscle I
myosin I
light I
chain I
kinase I
. O

Eight O
of O
the O
17 O
seropositive O
patients O
failed O
to O
develop O
detectable O
hepatitis B
B I
surface I
antibody I
within O
three O
months O
of O
the O
third O
injection O
compared O
with O
only O
one O
of O
the O
18 O
seronegative O
patients O
( O
p O
less O
than O
0 O
. O
01 O
) O
. O

Repression O
of O
the O
herpes B
simplex I
virus I
1 I
alpha I
4 I
gene I
by O
its O
gene O
product O
( O
ICP4 B
) O
within O
the O
context O
of O
the O
viral O
genome O
is O
conditioned O
by O
the O
distance O
and O
stereoaxial O
alignment O
of O
the O
ICP4 B
DNA I
binding I
site I
relative O
to O
the O
TATA O
box O
. O

Antibodies O
specific O
to O
the O
different O
members O
of O
the O
Jun B
and O
Fos B
family I
of I
transcription I
factors I
show O
that O
, O
in O
gel O
retardation O
assays O
, O
a O
Jun B
- I
like I
factor I
is O
a O
component O
of O
the O
H3 B
. I
2 I
specific I
complex I
. O

Moreover O
, O
site O
- O
specific O
integration O
of O
the O
ITR O
- O
flanked O
DNA O
was O
also O
detected O
by O
PCR O
amplification O
of O
the O
ITR B
- I
aavs1 I
junction I
in O
transduced O
human O
fibroblasts O
. O

Tubular O
dysfunction O
in O
renal O
lithiasis O
: O
cause O
or O
consequence O
? O
] O
To O
investigate O
whether O
overall O
tubular O
dysfunction O
is O
encountered O
in O
a O
particular O
subgroup O
of O
patients O
with O
urolithiasis O
, O
the O
following O
parameters O
of O
renal O
tubular O
function O
have O
been O
measured O
in O
fasting O
morning O
urine O
in O
124 O
male O
stone O
formers O
: O
excretion O
of O
lysozyme B
and O
gamma B
- I
glutamyl I
transpeptidase I
( O
gamma B
- I
GT I
) O
, O
fractional O
excretion O
( O
FE O
) O
or O
glucose O
, O
insulin B
, O
bicarbonate O
after O
an O
alkali O
load O
, O
and O
theoretical O
phosphate O
threshold O
( O
TmP O
/ O

Coexpression O
of O
c B
- I
Rel I
in O
combination O
with O
ATF B
- I
1 I
, O
CREB2 B
, O
or O
ATF B
- I
1 I
/ O
CREB2 B
leads O
to O
synergistic O
transactivation O
of O
a O
CD28RE B
- I
TRE I
reporter I
plasmid O
in O
quiescent O
Jurkat O
T O
- O
cells O
. O

A O
search O
was O
conducted O
for O
suppressors O
of O
the O
inositol O
auxotrophic O
phenotype O
of O
the O
ino4 B
- I
8 I
mutant I
of O
yeast O
. O

Paradoxically O
, O
loop O
3i O
from O
the O
M1Ach B
- I
muscarinic I
receptor I
also O
maximally O
inhibited O
GnRH B
agonist O
- O
stimulated O
cAMP O
accumulation O
and O
PRL B
release O
by O
40 O
% O
( O
both O
effects O
mediated O
through O
activation O
of O
the O
Gs B
protein I
) O
. O

Using O
beta B
1 I
- I
AR I
- O
luciferase B
reporter O
recombinants O
, O
we O
have O
previously O
determined O
that O
important O
beta B
1 I
- I
AR I
genetic O
elements O
controlling O
expression O
within O
the O
C6 O
glioma O
cell O
line O
are O
contained O
within O
the O
region O
- O
396 O
to O
- O
299 O
, O
relative O
to O
the O
translational O
start O
site O
. O

Using O
beta B
1 I
- I
AR I
- O
luciferase B
reporter O
recombinants O
, O
we O
have O
previously O
determined O
that O
important O
beta B
1 I
- I
AR I
genetic O
elements O
controlling O
expression O
within O
the O
C6 O
glioma O
cell O
line O
are O
contained O
within O
the O
region O
- O
396 O
to O
- O
299 O
, O
relative O
to O
the O
translational O
start O
site O
. O

Cotransfection O
experiments O
revealed O
that O
both O
hGATA B
- I
4 I
and O
PMA O
/ O
A23187 O
stimulation O
are O
necessary O
for O
the O
IL B
- I
5 I
promoter I
activation O
. O

Assays O
of O
APRE O
- O
luciferase B
reporter O
plasmids O
transfected O
into O
HepG2 O
cells O
show O
that O
a O
mutated O
APRE O
that O
binds O
only O
BPi B
functions O
as O
an O
IL B
- I
1 I
alpha I
inducible O
enhancer O
, O
whereas O
a O
mutated O
APRE O
that O
binds O
only O
BPc B
does O
not O
. O

The O
characterization O
of O
fly O
receptors O
with O
features O
similar O
to O
mammalian B
glycoprotein I
hormone I
receptors I
allows O
a O
better O
understanding O
of O
the O
evolution O
of O
this O
unique O
group O
of O
GPCRs B
and O
future O
elucidation O
of O
their O
ligand O
signaling O
mechanisms O
. O

Three O
putative O
ORFs O
have O
significant O
homology O
with O
known O
proteins O
: O
L0968 B
is O
a O
new O
member O
of O
the O
very O
large O
' B
seripauperins I
' I
family O
, O
comprising O
at O
least O
20 O
yeast O
members O
; O
L1313 B
is O
a O
new O
ABC B
transporter I
highly O
homologous O
to O
the O
yeast O
cadmium O
resistance O
protein O
Ycf1p B
and O
to O
the O
human B
multidrug I
resistance I
protein I
hMRP1 B
; O
the O
C O
- O
terminal O
part O
of O
L1325 B
present O
in O
our O
sequence O
is O
very O
homologous O
to O
the O
fruit O
fly O
abdominal O
segment O
formation O
protein O
Pumilio B
. O

Immunofluorescence O
obtained O
using O
antibodies O
against O
alphaI B
SigmaI I
/ I
+ I
+ I
betaI I
SigmaI I
spectrin I
and O
Abl B
tyrosine I
kinase I
but O
not O
against O
alphaII B
/ I
betaII I
spectrin I
colocalized O
with O
the O
overexpressed O
green B
fluorescent I
protein I
- O
SH3 B
- I
binding I
protein I
. O

Immunofluorescence O
obtained O
using O
antibodies O
against O
alphaI B
SigmaI I
/ I
+ I
+ I
betaI I
SigmaI I
spectrin I
and O
Abl B
tyrosine I
kinase I
but O
not O
against O
alphaII B
/ I
betaII I
spectrin I
colocalized O
with O
the O
overexpressed O
green B
fluorescent I
protein I
- O
SH3 B
- I
binding I
protein I
. O

Extracellular B
protein I
kinase I
A I
as O
a O
cancer O
biomarker O
: O
its O
expression O
by O
tumor O
cells O
and O
reversal O
by O
a O
myristate O
- O
lacking O
Calpha O
and O
RIIbeta O
subunit O
overexpression O
. O

MADS B
- I
box I
genes I
in O
plants O
are O
a O
diverse O
class O
of O
transcription O
factors O
that O
are O
involved O
in O
regulating O
developmental O
processes O
, O
particularly O
meristem O
and O
organ O
identity O
during O
floral O
development O
. O

CSEn B
stimulated O
transcription O
of O
a O
variety O
of O
promoters O
, O
including O
the O
hCS B
, O
human B
growth I
hormone I
, O
thymidine B
kinase I
, O
and O
Rous B
sarcoma I
virus I
promoters I
, O
in O
human O
choriocarcinoma O
cell O
lines O
( O
BeWo O
and O
JEG O
- O
3 O
) O
but O
not O
HeLa O
cells O
or O
rat O
somatolactotrophes O
( O
GC O
) O
. O

Pretreatment O
of O
human O
skin O
with O
tRA O
inhibited O
UV O
induction O
of O
c B
- I
Jun I
protein I
and O
, O
consequently O
, O
AP B
- I
1 I
. O

c B
- I
Jun I
protein I
inhibition O
occurred O
via O
a O
posttranscriptional O
mechanism O
, O
since O
tRA O
did O
not O
inhibit O
UV O
induction O
of O
c B
- I
Jun I
mRNA I
. O

c B
- I
Jun I
protein I
inhibition O
occurred O
via O
a O
posttranscriptional O
mechanism O
, O
since O
tRA O
did O
not O
inhibit O
UV O
induction O
of O
c B
- I
Jun I
mRNA I
. O

NGF B
also O
induced O
a O
synthetic O
promoter O
with O
repeated O
Sp1 B
sites I
linked O
to O
a O
core O
promoter O
, O
and O
a O
plasmid O
regulated O
by O
a O
chimeric O
transactivator O
in O
which O
the O
Gal4 B
DNA I
binding I
domain I
is O
fused O
to O
the O
Sp1 B
transactivation I
domain I
, O
indicating O
that O
this O
transactivation O
domain O
is O
regulated O
by O
NGF B
. O

Regulation O
of O
the O
p21 B
- I
activated I
kinase I
( O
PAK B
) O
by O
a O
human B
Gbeta I
- I
like I
WD O
- O
repeat O
protein O
, O
hPIP1 B
. O

Regulation O
of O
the O
p21 B
- I
activated I
kinase I
( O
PAK B
) O
by O
a O
human B
Gbeta I
- I
like I
WD O
- O
repeat O
protein O
, O
hPIP1 B
. O

APL O
patients O
showed O
a O
low O
, O
yet O
variable O
, O
level O
of O
JEM B
- I
1 I
mRNA I
in O
bone O
marrow O
. O

When O
transfected O
into O
HepG2 O
cells O
, O
which O
lack O
C B
/ I
EBP I
alpha I
, O
the O
mouse B
ob I
promoter I
was O
only O
weakly O
active O
. O

Messenger O
RNA O
for O
the O
Ad2 B
DNA I
binding I
protein I
: O
DNA O
sequences O
encoding O
the O
first O
leader O
and O
heterogenity O
at O
the O
mRNA O
5 O
' O
end O
. O

Transforming B
growth I
factor I
beta I
activates O
the O
promoter O
of O
cyclin B
- I
dependent I
kinase I
inhibitor O
p15INK4B B
through O
an O
Sp1 B
consensus I
site I
. O

Transforming B
growth I
factor I
beta I
activates O
the O
promoter O
of O
cyclin B
- I
dependent I
kinase I
inhibitor O
p15INK4B B
through O
an O
Sp1 B
consensus I
site I
. O

Previously O
, O
we O
identified O
two O
human B
SMC I
family I
proteins I
, O
hCAP B
- I
C I
and O
hCAP B
- I
E I
, O
which O
form O
a O
heterodimeric O
complex O
( O
hCAP B
- I
C I
- O
hCAP B
- I
E I
) O
in O
the O
cell O
. O

Methylation O
interference O
analysis O
established O
at O
single O
nucleotide O
resolution O
that O
purified O
recombinant O
Fos B
and O
Jun B
proteins I
bind O
in O
a O
sequence O
- O
specific O
manner O
to O
the O
AP B
- I
1 I
sites I
within O
the O
VDRE O
and O
OC B
box I
. O

Both O
the O
inactive O
domain B
II I
P68 I
mutant I
and O
the O
deletion O
mutant O
lacking O
aa O
91 O
- O
243 O
were O
less O
inhibitory O
to O
growth O
in O
yeast O
due O
to O
the O
reduced O
ability O
to O
phosphorylate O
initiation B
factor I
2 I
alpha I
in O
vivo O
. O

Both O
the O
inactive O
domain B
II I
P68 I
mutant I
and O
the O
deletion O
mutant O
lacking O
aa O
91 O
- O
243 O
were O
less O
inhibitory O
to O
growth O
in O
yeast O
due O
to O
the O
reduced O
ability O
to O
phosphorylate O
initiation B
factor I
2 I
alpha I
in O
vivo O
. O

Furthermore O
, O
we O
have O
identified O
the O
major O
open O
reading O
frame O
( O
RF4 O
; O
2 O
. O
3 O
kb O
) O
as O
being O
essential O
for O
activation O
, O
and O
we O
have O
shown O
that O
the O
NF B
kappa I
B I
, O
SP1 B
, O
and O
TATA O
box O
motifs O
in O
the O
human B
immunodeficiency I
virus I
LTR I
are O
all O
required O
for O
full O
induction O
of O
the O
promoter O
by O
the O
HHV B
- I
6 I
- I
encoded I
transactivator I
. O

Soluble O
extracts O
from O
FGF B
- O
treated O
as O
compared O
with O
quiescent O
fibroblasts O
exhibited O
up O
to O
3 O
- O
fold O
higher O
kinase O
activity O
towards O
S6 B
in O
exogenously O
added O
rat B
liver I
40S I
ribosomes I
and O
a O
synthetic O
peptide O
, O
RRLSSLRA O
. O

Candidate O
factors O
have O
been O
identified O
by O
the O
observation O
that O
changes O
in O
glucocorticoid O
induction O
parameters O
in O
CV O
- O
1 O
cells O
could O
be O
reproduced O
by O
varying O
the O
cellular O
levels O
of O
coactivators O
[ O
transcriptional B
intermediary I
factor I
2 I
( O
TIF2 B
) O
, O
steroid B
receptor I
coactivator I
1 I
( O
SRC B
- I
1 I
) O
, O
and O
amplified B
in I
breast I
cancer I
1 I
( O
AIB1 B
) O
] O
, O
comodulator O
[ O
CREB B
- I
binding I
protein I
( O
CBP B
) O
] O
, O
or O
corepressor O
[ O
silencing B
mediator I
for I
retinoid I
and I
thyroid I
- I
hormone I
receptors I
( O
SMRT B
) O
] O
without O

Candidate O
factors O
have O
been O
identified O
by O
the O
observation O
that O
changes O
in O
glucocorticoid O
induction O
parameters O
in O
CV O
- O
1 O
cells O
could O
be O
reproduced O
by O
varying O
the O
cellular O
levels O
of O
coactivators O
[ O
transcriptional B
intermediary I
factor I
2 I
( O
TIF2 B
) O
, O
steroid B
receptor I
coactivator I
1 I
( O
SRC B
- I
1 I
) O
, O
and O
amplified B
in I
breast I
cancer I
1 I
( O
AIB1 B
) O
] O
, O
comodulator O
[ O
CREB B
- I
binding I
protein I
( O
CBP B
) O
] O
, O
or O
corepressor O
[ O
silencing B
mediator I
for I
retinoid I
and I
thyroid I
- I
hormone I
receptors I
( O
SMRT B
) O
] O
without O

Candidate O
factors O
have O
been O
identified O
by O
the O
observation O
that O
changes O
in O
glucocorticoid O
induction O
parameters O
in O
CV O
- O
1 O
cells O
could O
be O
reproduced O
by O
varying O
the O
cellular O
levels O
of O
coactivators O
[ O
transcriptional B
intermediary I
factor I
2 I
( O
TIF2 B
) O
, O
steroid B
receptor I
coactivator I
1 I
( O
SRC B
- I
1 I
) O
, O
and O
amplified B
in I
breast I
cancer I
1 I
( O
AIB1 B
) O
] O
, O
comodulator O
[ O
CREB B
- I
binding I
protein I
( O
CBP B
) O
] O
, O
or O
corepressor O
[ O
silencing B
mediator I
for I
retinoid I
and I
thyroid I
- I
hormone I
receptors I
( O
SMRT B
) O
] O
without O

The O
sequence O
of O
the O
gene O
upstream O
to O
the O
cap O
site O
contains O
characteristic O
RNA B
polymerase I
II I
promoter I
- I
binding I
sites I
: O
a O
putative O
TATA O
box O
at O
position O
- O
29 O
and O
a O
Sp B
1 I
binding I
site I
( O
GGGGCGGAGA O
) O
at O
position O
- O
48 O
. O

Nuclear O
transcription O
assays O
confirmed O
that O
cys B
- I
3 I
+ I
was O
under O
sulfur O
- O
regulated O
transcriptional O
control O
and O
that O
cys B
- I
3 I
+ I
transcription O
was O
constitutive O
in O
sulfur B
controller I
( O
scon B
) O
- O
negative O
regulator O
mutants O
. O

Nuclear O
transcription O
assays O
confirmed O
that O
cys B
- I
3 I
+ I
was O
under O
sulfur O
- O
regulated O
transcriptional O
control O
and O
that O
cys B
- I
3 I
+ I
transcription O
was O
constitutive O
in O
sulfur B
controller I
( O
scon B
) O
- O
negative O
regulator O
mutants O
. O

Deletion O
mutagenesis O
of O
the O
promoter O
indicated O
that O
a O
positive O
regulatory O
element O
( O
PRE O
) O
was O
likely O
to O
exist O
downstream O
of O
the O
UL94 B
mRNA I
start I
site I
, O
while O
a O
negative O
regulatory O
element O
( O
NRE O
) O
was O
present O
upstream O
of O
the O
TATA O
box O
. O

Further O
, O
more O
recent O
communications O
suggest O
that O
liver O
disease O
led O
to O
a O
differential O
alteration O
of O
the O
cytochrome B
P I
- I
450s I
with O
regard O
to O
protein O
content O
and O
activity O
. O

Base O
substitutions O
within O
this O
NFIL B
- I
6 I
site I
resulted O
in O
virtual O
elimination O
of O
LPS O
- O
induced O
IL B
- I
1 I
beta I
gene I
transcription O
. O

Collectively O
, O
a O
unique O
mechanism O
involving O
NF B
- I
ATp I
appears O
to O
regulate O
the O
cell O
type O
- O
specific O
and O
activation O
- O
dependent O
expression O
of O
the O
SCM B
- I
1 I
genes I
. O

A O
DNA O
fragment O
that O
complements O
the O
uvs B
- I
2 I
mutation O
was O
subcloned O
by O
monitoring O
its O
ability O
to O
transform O
the O
uvs B
- I
2 I
mutant I
to O
MMS O
resistance O
. O

The O
human B
lbc I
oncogene I
product I
is O
a O
guanine B
nucleotide I
exchange I
factor I
that O
specifically O
activates O
the O
Rho B
small I
GTP I
binding I
protein I
, O
thus O
resulting O
in O
biologically O
active O
, O
GTP O
- O
bound O
Rho B
, O
which O
in O
turn O
mediates O
actin B
cytoskeletal O
reorganization O
, O
gene O
transcription O
, O
and O
entry O
into O
the O
mitotic O
S O
phase O
. O

The O
human B
lbc I
oncogene I
product I
is O
a O
guanine B
nucleotide I
exchange I
factor I
that O
specifically O
activates O
the O
Rho B
small I
GTP I
binding I
protein I
, O
thus O
resulting O
in O
biologically O
active O
, O
GTP O
- O
bound O
Rho B
, O
which O
in O
turn O
mediates O
actin B
cytoskeletal O
reorganization O
, O
gene O
transcription O
, O
and O
entry O
into O
the O
mitotic O
S O
phase O
. O

The O
results O
of O
these O
studies O
indicate O
that O
EHV B
- I
1 I
gp13 I
is O
the O
structural O
homolog O
of O
herpes B
simplex I
virus I
glycoprotein I
C I
and O
further O
suggest O
that O
the O
epitope O
- O
containing O
N O
- O
terminal O
amino O
acid O
sequences O
of O
the O
herpesvirus B
gC I
- I
like I
glycoproteins I
have O
undergone O
more O
extensive O
evolutionary O
divergence O
than O
the O
C O
- O
terminal O
sequences O
. O

By O
contrast O
, O
footprint O
II O
at O
position O
- O
125 O
is O
common O
to O
both O
HeLa O
and O
GH3 O
cell O
extracts O
and O
overlies O
a O
15 O
- O
base O
- O
pair O
sequence O
found O
in O
all O
members O
of O
the O
growth B
hormone I
gene I
family I
. O

Highly O
conserved O
regions O
called O
src B
homology I
2 I
and O
3 O
( O
SH2 B
and O
SH3 B
) O
, O
comprising O
amino O
acid O
residues O
88 O
to O
250 O
, O
are O
believed O
to O
modulate O
the O
protein B
- I
tyrosine I
kinase I
activity O
present O
in O
the O
carboxy O
- O
terminal O
halves O
of O
the O
src B
proteins I
. O

We O
propose O
2 O
separate O
PAI B
- I
1 I
inductory O
pathways O
for O
PMA O
and O
IL B
- I
1alpha I
in O
HepG2 O
, O
both O
involving O
protein B
tyrosine I
kinase I
activation O
; O
the O
serum O
- O
induced O
signaling O
pathway O
may O
( O
partially O
) O
overlap O
with O
the O
PMA O
- O
activated O
protein B
kinase I
C I
/ O
mitogen B
- I
activated I
protein I
kinase I
kinase I
pathway O
, O
leading O
to O
c B
- I
Jun I
homodimer I
binding O
to O
the O
PAI B
- I
1 I
TRE O
. O

We O
show O
that O
sae1 B
- I
1 I
and O
sae3 B
- I
1 I
mutations I
each O
confer O
a O
distinct O
defect O
in O
meiotic O
recombination O
. O

G6620 B
is O
the O
3 O
' O
end O
of O
the O
MOL1 B
gene I
coding O
for O
a O
polypeptide O
similar O
to O
stress O
- O
inducible O
proteins O
from O
Fusarium O
; O
G6630 B
is O
the O
NAT2 B
gene I
which O
encodes O
a O
methionine B
N I
- I
acetyltransferase I
; O
G6635 B
is O
the O
RPL30B B
gene I
coding O
for O
the O
ribosomal B
protein I
L30 I
; O
G6658 B
is O
RSR1 B
encoding O
a O
ras B
- I
related I
protein I
; O
G6667 B
is O
CYS4 B
, O
the O
gene O
for O
cystathionine B
beta I
- I
synthase I

G6620 B
is O
the O
3 O
' O
end O
of O
the O
MOL1 B
gene I
coding O
for O
a O
polypeptide O
similar O
to O
stress O
- O
inducible O
proteins O
from O
Fusarium O
; O
G6630 B
is O
the O
NAT2 B
gene I
which O
encodes O
a O
methionine B
N I
- I
acetyltransferase I
; O
G6635 B
is O
the O
RPL30B B
gene I
coding O
for O
the O
ribosomal B
protein I
L30 I
; O
G6658 B
is O
RSR1 B
encoding O
a O
ras B
- I
related I
protein I
; O
G6667 B
is O
CYS4 B
, O
the O
gene O
for O
cystathionine B
beta I
- I
synthase I

Meq B
/ O
c B
- I
Jun I
heterodimers O
bind O
to O
an O
AP1 B
- I
like I
sequence I
in O
the O
meq B
promoter I
region I
with O
an O
affinity O
much O
greater O
than O
that O
of O
Meq B
/ O
Meq B
or O
c B
- I
Jun I
/ O
c B
- I
Jun I
homodimers O
. O

Nonlethal O
sec71 B
- I
1 I
and O
sec72 B
- I
1 I
mutations I
eliminate O
proteins O
associated O
with O
the O
Sec63p B
- O
BiP B
complex O
from O
S O
. O
cerevisiae O
. O

This O
polypeptide O
includes O
the O
first O
three O
zinc O
fingers O
of O
the O
TFIIIA B
DNA I
binding I
domain I
. O

An O
exception O
is O
the O
Bcl B
- I
6 I
gene I
, O
encoding O
a O
transcription O
factor O
, O
which O
was O
found O
to O
be O
mutated O
in O
normal O
human O
memory O
B O
cells O
. O

Similarly O
, O
TAM B
- I
67 I
reverted O
the O
morphology O
of O
the O
AdoMetDC B
- I
antisense I
expressors I
. O

GH B
induced O
rapid O
tyrosine O
phosphorylation O
of O
a O
protein O
at O
approximately O
93 O
kDa O
in O
normal O
fibroblasts O
, O
and O
Western O
blotting O
with O
STAT B
- I
specific I
antibodies I
revealed O
STAT5 B
activation O
( O
phosphorylation O
) O
by O
GH O
. O

The O
cdc42W97R B
temperature I
- I
sensitive I
allele I
in O
S O
. O
cerevisiae O
displayed O
the O
same O
cell O
- O
division O
- O
cycle O
arrest O
phenotype O
( O
large O
, O
round O
unbudded O
cells O
) O
as O
the O
cdc42 B
- I
1ts I
mutant I
. O

Recombinant O
vaccinia O
viruses O
that O
express O
the O
bacteriophage B
T3 I
RNA I
polymerase I
( O
VV B
- I
T3pol I
) O
or O
the O
Escherichia B
coli I
lac I
repressor I
( O
VV B
- I
lacI I
) O
under O
control O
of O
the O
early B
- I
late I
vaccinia I
promoter I
P7 I
. I
5 I
were O
constructed O
. O

Recombinant O
vaccinia O
viruses O
that O
express O
the O
bacteriophage B
T3 I
RNA I
polymerase I
( O
VV B
- I
T3pol I
) O
or O
the O
Escherichia B
coli I
lac I
repressor I
( O
VV B
- I
lacI I
) O
under O
control O
of O
the O
early B
- I
late I
vaccinia I
promoter I
P7 I
. I
5 I
were O
constructed O
. O

Concerning O
the O
practical O
approach O
in O
a O
clinical O
setting O
, O
it O
has O
to O
be O
pointed O
out O
that O
with O
these O
diseases O
a O
hepatitis O
C O
infection O
has O
to O
be O
considered O
and O
testing O
for O
hepatitis B
C I
antibodies I
and O
, O
if O
positive O
, O
hepatitis B
C I
- I
RNA I
is O
indicated O
. O

In O
both O
cell O
types O
, O
insulin B
led O
to O
a O
dose O
- O
dependent O
increase O
in O
the O
association O
of O
tyrosine B
phosphorylated I
IRS I
- I
1 I
with O
the O
SH2 B
domain I
of O
the O
p85 B
regulatory I
subunit I
of O
PI B
- I
3 I
kinase I
, O
and O
also O
increased O
the O
amount O
of O
PI B
kinase I
activity O
detected O
in O
anti B
- I
IRS I
- I
1 I
immunoprecipitates O
. O

A O
transient O
induction O
of O
both O
c B
- I
fos I
and O
c B
- I
jun I
mRNAs I
by O
TPA O
was O
observed O
in O
both O
cell O
populations O
, O
together O
with O
an O
associated O
suppression O
of O
BSP B
mRNA I
in O
the O
fetal O
rat O
calvarial O
cells O
. O

This O
enhancer O
element O
functioned O
in O
a O
position O
- O
and O
orientation O
- O
independent O
manner O
both O
on O
the O
Pax B
- I
QNR I
P0 I
promoter I
and O
the O
heterologous B
thymidine I
kinase I
promoter I
. O

Our O
results O
suggest O
a O
biological O
role O
for O
Elf B
- I
1 I
in O
the O
regulation O
of O
IgH B
gene I
expression O
, O
attribute O
a O
functional O
role O
for O
receptor O
- O
induced O
AP B
- I
1 I
proteins I
in O
B O
lymphocytes O
and O
provide O
evidence O
for O
a O
direct O
link O
between O
IgM B
receptor I
- O
mediated O
signalling O
and O
3 O
' O
enhancer O
activation O
. O

Detailed O
analysis O
of O
the O
predicted O
amino O
acid O
sequence O
revealed O
sequence O
elements O
which O
are O
conserved O
in O
many O
DNA B
and I
RNA I
polymerases I
. O

The O
CydDC B
system I
appears O
to O
be O
the O
first O
prokaryotic O
example O
of O
a O
heterodimeric B
ABC I
transport I
system I
in O
which O
each O
polypeptide O
contains O
both O
hydrophobic O
and O
ATP O
- O
binding O
domains O
. O

The O
coding O
sequence O
of O
rat B
MEK I
kinase I
1 I
( O
MEKK1 B
) O
has O
been O
determined O
from O
multiple O
, O
independent O
cDNA O
clones O
. O

Profilins B
IIa I
and I
IIb I
are O
also O
present O
in O
humans O
, O
suggesting O
that O
all O
mammals O
have O
three O
profilin B
isoforms I
. O

VP4 B
differentially O
regulates O
TRAF2 B
signaling O
, O
disengaging O
JNK B
activation O
while O
directing O
NF B
- I
kappa I
B I
to O
effect O
rotavirus O
- O
specific O
cellular O
responses O
. O

Moreover O
, O
we O
show O
that O
GATA B
- I
1 I
and O
Sp1 B
synergize O
from O
a O
distance O
in O
constructs O
designed O
to O
mimic O
the O
architecture O
of O
globin B
locus I
control I
regions I
and O
downstream O
globin B
promoters I
. O

Mammalian O
chromosome O
ends O
contain O
long O
arrays O
of O
TTAGGG O
repeats O
that O
are O
complexed O
to O
a O
telomere O
specific O
protein O
, O
the O
TTAGGG B
repeat I
binding I
factor I
, O
TRF1 B
. O

The O
fusion O
gene O
cassette O
was O
placed O
under O
the O
control O
of O
a O
vaccinia B
virus I
early I
promoter I
and O
cloned O
in O
a O
host O
- O
restricted O
fowlpox O
viral O
vector O
. O

Fulminant O
hepatic O
failure O
in O
these O
cases O
could O
be O
characterized O
by O
: O
( O
1 O
) O
rapid O
decrease O
in O
serum B
alanine I
transaminase I
( O
ALT B
) O
level O
after O
discontinuation O
of O
ecarazine O
, O
( O
2 O
) O
prolonged O
jaundice O
despite O
discontinuation O
of O
ecarazine O
, O
( O
3 O
) O
high O
incidence O
of O
anti B
- I
nuclear I
antibody I
( O
ANA B
) O
( O
57 O
% O
) O
, O
and O
( O
4 O
) O
histological O
findings O
of O
extensive O
hepatocellular O
necrosis O
ranging O
from O
bridging O
necrosis O
to O
massive O
necrosis O
. O

Thus O
, O
the O
rates O
of O
a B
- I
factor I
receptor I
endocytosis O
and O
consequent O
vacuolar O
turnover O
depend O
on O
the O
available O
level O
of O
ubiquitin B
in O
the O
cell O
. O

The O
cyclin B
- I
dependent I
kinase I
Cdk2 B
associates O
with O
cyclins B
A I
, I
D I
, I
and I
E I
and O
has O
been O
implicated O
in O
the O
control O
of O
the O
G1 O
to O
S O
phase O
transition O
in O
mammals O
. O

The O
activity O
of O
gamma B
- I
glutamyl I
transpeptidase I
in O
the O
serum O
of O
problem O
drinkers O
. O

We O
have O
analyzed O
the O
function O
of O
these O
putative O
SL O
structures O
in O
RNA O
translation O
by O
constructing O
chimeric B
chloramphenicol I
acetyltransferase I
( B
CAT I
) I
RNAs I
, O
flanked O
either O
by O
both O
5 O
' O
- O
and O
3 O
' O
- O
terminal O
sequence O
domains O
from O
the O
RV O
genome O
or O
several O
deletion O
derivatives O
of O
the O
same O
sequences O
. O

5 O
' O
- O
Deletion O
of O
the O
Stat B
- I
binding I
sites I
abolished O
all O
promoter O
- O
reporter O
activity O
in O
response O
to O
PRL B
. O

Plasma B
beta I
- I
thromboglobulin I
( O
beta B
- I
TG I
) O
, O
a O
platelet O
- O
specific O
protein O
, O
is O
a O
marker O
of O
intravascular O
platelet O
degranulation O
. O

The O
DNA O
element O
through O
which O
EBNA B
- I
3C I
activates O
the O
LMP B
- I
1 I
promoter I
includes O
a O
Spi B
- I
1 I
/ O
Spi B
- I
B I
binding O
site O
, O
previously O
characterized O
as O
an O
important O
EBNA B
- I
2 I
response I
element I
. O

Furthermore O
, O
deletion O
of O
two O
potential O
Ste11 B
recognition I
sites I
in O
the O
fus1 B
promoter I
region O
abolished O
transcription O
, O
and O
expression O
could O
be O
restored O
when O
we O
inserted O
a O
different O
Ste11 B
site I
from O
the O
mat1 B
- I
P I
promoter I
. O

To O
further O
investigate O
the O
role O
of O
PKR B
in O
transcriptional O
signaling O
, O
we O
expressed O
the O
wild B
type I
human I
PKR I
and O
a O
catalytically O
inactive O
dominant O
negative O
PKR B
mutant I
in O
the O
murine O
pre O
- O
B O
lymphoma O
70Z O
/ O
3 O
cells O
. O

Selective O
upper O
abdominal O
sympathectomy O
increased O
basal O
acid O
output O
in O
rats O
but O
was O
without O
effect O
on O
stimulated O
acid O
output O
, O
serum B
gastrin I
concentration O
, O
and O
gastric B
mucosal I
histidine I
decarboxylase I
activity O
. O

The O
protein O
contains O
a O
SHAQKYF O
amino O
acid O
signature O
motif O
in O
the O
second O
myb B
- I
like I
repeat I
, O
which O
is O
highly O
conserved O
in O
a O
number O
of O
recently O
identified O
plant B
myb I
- I
related I
genes I
, O
thus O
defining O
a O
new O
class O
of O
plant O
DNA O
- O
binding O
proteins O
. O

To O
initiate O
our O
analysis O
of O
factors O
required O
for O
eIF B
- I
2 I
alpha I
expression O
, O
selected O
a O
CAP O
- O
proximal O
element O
shown O
by O
in O
vivo O
methylation O
protection O
analysis O
to O
bind O
a O
potential O
regulatory O
factor O
. O

Conversely O
, O
as O
a O
GAL B
- I
4 I
chimera I
, O
the O
isolated O
LAZ3 B
/ O
BCL6 B
BTB B
/ O
POZ O
domain O
appears O
nearly O
as O
efficient O
as O
the O
entire O
protein O
at O
inducing O
transcriptional O
repression O
. O

The O
LS B
gene I
promoter I
sequence I
has O
homology O
with O
Escherichia O
coli O
promoter O
sequences O
; O
its O
terminator O
sequence O
is O
capable O
of O
forming O
a O
stem O
- O
and O
- O
loop O
structure O
. O

mCgA B
- O
92 O
to O
- O
64 O
bp O
, O
comprising O
the O
Sp1 B
/ O
Egr B
- I
1 I
site O
and O
the O
CRE O
motif O
, O
conferred O
gastrin B
responsiveness O
to O
a O
heterologous B
thymidine I
kinase I
promoter I
system O
, O
and O
therefore O
functions O
as O
a O
" O
true O
" O
enhancer O
element O
. O

13 O
: O
961 O
- O
969 O
, O
1993 O
) O
suggested O
that O
T B
antigen I
could O
mediate O
transcriptional O
activation O
through O
interaction O
with O
the O
TATA B
- I
binding I
protein I
, O
as O
well O
as O
upstream O
bound O
transcription O
factors O
. O

More O
important O
, O
ligand O
- O
activated O
insulin B
and O
IGF B
- I
I I
receptors I
phosphorylate O
SHC B
proteins I
in O
vitro O
, O
indicating O
that O
SHC B
proteins I
could O
be O
direct O
substrates O
for O
insulin B
and O
IGF B
- I
I I
receptors I
. O

More O
important O
, O
ligand O
- O
activated O
insulin B
and O
IGF B
- I
I I
receptors I
phosphorylate O
SHC B
proteins I
in O
vitro O
, O
indicating O
that O
SHC B
proteins I
could O
be O
direct O
substrates O
for O
insulin B
and O
IGF B
- I
I I
receptors I
. O

We O
describe O
a O
novel O
stat B
- I
related I
factor I
, O
p93 B
, O
that O
is O
found O
in O
EGF B
- O
treated O
A431 O
cell O
extracts O
but O
appears O
to O
be O
absent O
in O
bovine B
fibroblast I
growth I
factor I
( O
bFGF B
) O
, O
IFN B
- I
gamma I
, O
tumor B
necrosis I
factor I
- I
alpha I
( O
TNF B
- I
alpha I
) O
, O
and O
untreated O
cells O
. O

We O
describe O
a O
novel O
stat B
- I
related I
factor I
, O
p93 B
, O
that O
is O
found O
in O
EGF B
- O
treated O
A431 O
cell O
extracts O
but O
appears O
to O
be O
absent O
in O
bovine B
fibroblast I
growth I
factor I
( O
bFGF B
) O
, O
IFN B
- I
gamma I
, O
tumor B
necrosis I
factor I
- I
alpha I
( O
TNF B
- I
alpha I
) O
, O
and O
untreated O
cells O
. O

In O
addition O
, O
Fc B
epsilon I
R1 I
cross O
- O
linking O
activates O
PI B
3 I
- I
kinase I
. O

Thus O
, O
STK1 B
is O
most O
likely O
the O
human B
homologue I
of I
MO15 I
. O

BACKGROUND O
: O
Recent O
iterative O
methods O
for O
sequence O
alignment O
have O
indicated O
that O
the O
380 O
kDa O
motor O
unit O
of O
dynein B
belongs O
to O
the O
AAA B
class I
of O
chaperone B
- I
like I
ATPases I
. O

When O
the O
VBP B
- I
1 I
protein I
was O
solely O
expressed O
, O
it O
located O
to O
the O
cytoplasm O
and O
did O
not O
localize O
to O
the O
nucleus O
. O

Blood B
coagulation I
Factor I
X I
and O
its O
activated O
form O
Factor B
Xa I
play O
an O
essential O
role O
in O
the O
midphase O
of O
the O
clotting O
cascade O
. O

Hematopoietic B
progenitor I
kinase I
1 I
( O
HPK1 B
) O
is O
a O
member O
of O
the O
mitogen B
- I
activated I
protein I
kinase I
kinase I
kinase I
kinase I
( O
MAP4K B
) O
family O
and O
an O
upstream O
activator O
of O
the O
c B
- I
Jun I
N I
- I
terminal I
kinase I
( O
JNK B
) O
signaling O
cascade O
. O

Finally O
, O
the O
conservation O
of O
the O
two O
residues O
most O
sensitive O
to O
mutations O
( O
Y949 O
and O
Y953 O
) O
in O
TM11 O
, O
and O
in O
the O
homologous O
TM5 O
, O
of O
all O
mammalian B
P I
- I
gps I
and O
also O
in O
other O
ABC B
transporters I
, O
suggests O
that O
these O
residues O
and O
domains O
may O
play O
an O
important O
role O
in O
structural O
as O
well O
as O
mechanistic O
aspects O
common O
to O
this O
family O
of O
proteins O
. O

Furthermore O
, O
we O
show O
that O
Nck B
- I
2 I
is O
capable O
of O
recognizing O
several O
key O
components O
of O
growth B
factor I
receptor I
kinase I
- O
signaling O
pathways O
including O
EGF B
receptors I
, O
PDGF B
receptor I
- I
beta I
, O
and O
IRS B
- I
1 I
. O

Furthermore O
, O
we O
show O
that O
Nck B
- I
2 I
is O
capable O
of O
recognizing O
several O
key O
components O
of O
growth B
factor I
receptor I
kinase I
- O
signaling O
pathways O
including O
EGF B
receptors I
, O
PDGF B
receptor I
- I
beta I
, O
and O
IRS B
- I
1 I
. O

Protein O
sequencing O
, O
electrophoretic O
mobility O
shift O
assay O
, O
and O
immunoblot O
analyses O
identify O
p54 B
and O
p47 B
/ I
48 I
as O
members O
of O
the O
hepatocyte B
nuclear I
factor I
3 I
( O
HNF3 B
[ O
forkhead B
] O
) O
family O
of O
transcription O
factors O
. O

Expression O
, O
characterization O
, O
and O
genomic O
structure O
of O
carp B
JAK1 I
kinase I
gene I
. O

This O
result O
, O
together O
with O
the O
fact O
that O
unrearranged B
V I
kappa I
genes I
are O
transcriptionally O
silent O
, O
suggests O
that O
structural O
features O
of O
both O
the O
V B
kappa I
and O
C B
kappa I
loci I
contribute O
to O
the O
overall O
transcriptional O
efficiency O
of O
a O
rearranged O
V B
kappa I
- O
C B
kappa I
gene O
. O

In O
addition O
, O
there O
was O
an O
increase O
in O
the O
amount O
of O
p120 B
Ras I
- O
specific O
GTPase B
- I
activating I
protein I
( O
GAP B
) O
and O
GAP B
- O
associated O
p190 O
. O

The O
relationship O
between O
donor O
status O
for O
antibody O
to O
hepatitis B
B I
core I
antigen I
and O
the O
occurrence O
of O
non O
- O
A O
, O
non O
- O
B O
posttransfusion O
hepatitis O
in O
the O
recipient O
was O
prospectively O
studied O
in O
112 O
patients O
undergoing O
open O
- O
heart O
surgery O
who O
were O
followed O
for O
6 O
. O
5 O
months O
after O
surgery O
. O

Brome B
mosaic I
virus I
polymerase I
- O
like O
protein B
2a I
is O
directed O
to O
the O
endoplasmic O
reticulum O
by O
helicase B
- O
like O
viral B
protein I
1a I
. O

The O
avian O
carcinoma O
virus O
MH2 O
contains O
a O
hybrid O
gene O
delta B
gag I
- O
mht B
with O
a O
contiguous O
open O
reading O
frame O
of O
2682 O
base O
pairs O
as O
well O
as O
v B
- I
myc I
and O
avian O
helper O
virus O
- O
related O
sequences O
. O
delta B
gag I
is O
a O
partial O
retroviral B
core I
protein I
gene I
while O
v B
- I
mht I
and O
v B
- I
myc I
are O
cell O
- O
drived O
sequences O
. O

Both O
proteins O
share O
sequence O
similarity O
with O
the O
myelin B
- I
associated I
glycoprotein I
, O
an O
adhesion O
molecule O
of O
oligodendrocytes O
and O
Schwann O
cells O
that O
has O
been O
implicated O
in O
the O
process O
of O
myelination O
, O
raising O
the O
important O
question O
of O
whether O
myelin B
- I
associated I
glycoprotein I
is O
also O
a O
sialic B
acid I
- I
binding I
protein I
. O

Both O
proteins O
share O
sequence O
similarity O
with O
the O
myelin B
- I
associated I
glycoprotein I
, O
an O
adhesion O
molecule O
of O
oligodendrocytes O
and O
Schwann O
cells O
that O
has O
been O
implicated O
in O
the O
process O
of O
myelination O
, O
raising O
the O
important O
question O
of O
whether O
myelin B
- I
associated I
glycoprotein I
is O
also O
a O
sialic B
acid I
- I
binding I
protein I
. O

Localized O
Bicaudal B
- I
C I
RNA I
encodes O
a O
protein O
containing O
a O
KH O
domain O
, O
the O
RNA O
binding O
motif O
of O
FMR1 B
. O

The O
JNK B
/ O
SAPK B
activator O
mixed B
lineage I
kinase I
3 I
( O
MLK3 B
) O
transforms O
NIH O
3T3 O
cells O
in O
a O
MEK B
- O
dependent O
fashion O
. O

The O
related O
adhesion B
focal I
tyrosine I
kinase I
is O
tyrosine O
- O
phosphorylated O
after O
beta1 B
- I
integrin I
stimulation O
in O
B O
cells O
and O
binds O
to O
p130cas B
. O

The O
rec8 B
( I
+ I
) I
, O
rec10 B
( I
+ I
) I
, O
and O
rec11 B
( I
+ I
) I
genes I
of I
the I
fission I
yeast I
Schizosaccharomyces I
pombe I
exhibit O
similar O
specificities O
for O
meiotic O
recombination O
and O
rec8 B
( I
+ I
) I
is O
required O
for O
sister O
chromatid O
cohesion O
and O
homolog O
pairing O
. O

The O
rec8 B
( I
+ I
) I
, O
rec10 B
( I
+ I
) I
, O
and O
rec11 B
( I
+ I
) I
genes I
of I
the I
fission I
yeast I
Schizosaccharomyces I
pombe I
exhibit O
similar O
specificities O
for O
meiotic O
recombination O
and O
rec8 B
( I
+ I
) I
is O
required O
for O
sister O
chromatid O
cohesion O
and O
homolog O
pairing O
. O

The O
rec8 B
( I
+ I
) I
, O
rec10 B
( I
+ I
) I
, O
and O
rec11 B
( I
+ I
) I
genes I
of I
the I
fission I
yeast I
Schizosaccharomyces I
pombe I
exhibit O
similar O
specificities O
for O
meiotic O
recombination O
and O
rec8 B
( I
+ I
) I
is O
required O
for O
sister O
chromatid O
cohesion O
and O
homolog O
pairing O
. O

Analysis O
of O
the O
DNA O
sequence O
upstream O
of O
the O
narQ B
gene I
, O
which O
encodes O
the O
second O
nitrate O
- O
responsive O
sensor O
- O
transmitter O
protein O
in O
Escherichia O
coli O
, O
revealed O
an O
open O
reading O
frame O
( O
ORF O
) O
whose O
product O
shows O
a O
high O
degree O
of O
similarity O
to O
a O
number O
of O
iron B
- I
sulfur I
proteins I
as O
well O
as O
to O
the O
beta O
subunit O
of O
glutamate B
synthase I
( O
gltD B
) O
of O
E O
. O
coli O
. O

Thus O
, O
Tax1 B
activates O
CArG O
- O
mediated O
transcription O
without O
mitogenic O
signals O
through O
interaction O
with O
a O
CArG B
- I
binding I
factor I
, O
p67SRF B
. O

When O
translated O
in O
- O
frame O
with O
PKC B
zeta I
, O
a O
stop O
codon O
is O
located O
28 O
amino O
acids O
towards O
the O
N O
- O
terminus O
of O
the O
divergence O
point O
and O
the O
intervening O
sequence O
lacks O
an O
expected O
initiating O
methionine O
. O
psi B
PKC I
zeta I
is O
non O
- O
functional O
in O
terms O
of O
protein O
synthesis O
since O
Western O
blotting O
with O
an O
antibody O
directed O
against O
the O
C O
- O
terminus O
of O
PKC B
zeta I
failed O
to O
reveal O
a O
protein O
smaller O
than O
PKC B
zeta I
, O
and O
synthetic O
psi B
PKC I
zeta I
RNA I
failed O
to O
support O
protein O
synthesis O
in O
a O
translation O
system O
in O
vitro O
. O

Two O
genes O
from O
the O
family O
encoding O
mouse B
ribosomal I
protein I
S16 I
were O
cloned O
, O
sequenced O
, O
and O
analyzed O
. O

The O
human O
protein O
binds O
most O
strongly O
to O
the O
SH3 B
domain I
from O
the O
abl B
proto I
- I
oncogene I
. O

These O
data O
show O
that O
tyrosine O
phosphorylation O
by O
FES B
affects O
the O
interaction O
of O
BCR B
with O
multiple O
signaling O
partners O
and O
suggest O
a O
general O
role O
for O
BCR B
in O
non O
- O
receptor O
protein B
- I
tyrosine I
kinase I
regulation O
and O
signal O
transduction O
. O

Because O
the O
wa B
- I
2 I
mutation I
was O
mapped O
previously O
to O
the O
vicinity O
of O
the O
EGF B
/ I
TGF I
- I
alpha I
receptor I
( O
EGFR B
) O
gene O
on O
mouse O
chromosome O
11 O
, O
we O
hypothesized O
that O
the O
wa B
- I
2 I
phenotype I
might O
result O
from O
a O
defect O
in O
either O
the O
expression O
or O
activity O
of O
EGFR B
, O
or O
both O
. O

Because O
the O
wa B
- I
2 I
mutation I
was O
mapped O
previously O
to O
the O
vicinity O
of O
the O
EGF B
/ I
TGF I
- I
alpha I
receptor I
( O
EGFR B
) O
gene O
on O
mouse O
chromosome O
11 O
, O
we O
hypothesized O
that O
the O
wa B
- I
2 I
phenotype I
might O
result O
from O
a O
defect O
in O
either O
the O
expression O
or O
activity O
of O
EGFR B
, O
or O
both O
. O

Thus O
, O
the O
i B
- I
leader I
protein I
is O
a O
viral O
gene O
product O
of O
unknown O
function O
and O
high O
stability O
that O
is O
made O
in O
large O
quantities O
at O
intermediate O
times O
of O
productive O
infection O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

IgE B
- I
binding I
proteins I
of O
Psocoptera O
were O
determined O
by O
immunoblotting O
experiments O
. O

Hybridization O
was O
detected O
between O
polyadenylated B
H I
chain I
mRNA I
, O
isolated O
from O
the O
majority O
of O
the O
hybridomas O
, O
and O
the O
VH B
probe O
. O

Evaluation O
of O
gamma B
- I
glutamyl I
transpeptidase I
in O
myocardial O
infarction O
. O

We O
previously O
identified O
a O
highly O
conserved O
L O
- O
X O
- O
X O
- O
L O
- O
F O
sequence O
near O
the O
C O
terminus O
of O
the O
p6 B
domain I
of O
the O
Gag B
precursor I
as O
the O
major O
virion O
association O
motif O
for O
HIV B
- I
1 I
Vpr I
. O

An O
anoerxiant O
, O
mazindol O
suppresses O
food O
intake O
by O
1 O
) O
stimulating O
beta B
- I
adrenergic I
receptors I
, O
2 O
) O
inhibiting O
the O
feeding O
center O
and O
, O
3 O
) O
stimulating O
the O
satiety O
center O
in O
the O
hypothalamus O
. O

This O
50 O
- O
kDa O
protein O
contains O
two O
SH2 B
domains I
and O
an O
inter B
- I
SH2 I
domain I
of O
p85alpha B
, O
but O
the O
SH3 B
and O
bcr B
homology I
domains I
of O
p85alpha B
were O
replaced O
by O
a O
unique O
6 O
- O
amino O
acid O
sequence O
. O

The O
model O
of O
the O
complex O
provides O
a O
rationale O
for O
conserved O
ITAM B
residues O
, O
substrate O
specificity O
, O
and O
suggests O
that O
substrate O
binds O
only O
the O
active O
conformation O
of O
the O
Src B
family I
tyrosine I
kinase I
, O
unlike O
the O
ATP O
cofactor O
, O
which O
can O
bind O
the O
inactive O
form O
. O

S O
- O
phase O
- O
promoting O
cyclin B
- I
dependent I
kinases I
( O
Cdks B
) O
and O
the O
kinase O
Dbf4 B
- O
Cdc7 B
then O
act O
to O
initiate O
replication O
. O

K562 O
erythroleukemia O
cells O
stably O
transfected O
with O
constructs O
containing O
the O
human B
Agamma I
- I
globin I
promoter I
linked O
to O
an O
enhanced B
green I
fluorescent I
protein I
( O
EGFP B
) O
reporter O
, O
with O
or O
without O
HS2 O
, O
were O
analyzed O
for O
EGFP B
expression O
by O
flow O
cytometry O
. O

Members O
of O
the O
CRE B
- I
binding I
protein I
( O
CREB B
) O
/ O
activating B
transcription I
factor I
transcription O
family O
as O
well O
as O
members O
of O
the O
Jun B
/ O
Fos B
family O
have O
been O
shown O
to O
bind O
to O
this O
sequence O
. O

Toward O
this O
end O
, O
we O
used O
two O
cultured O
colon O
cancer O
cell O
lines O
; O
one O
( O
RKO O
) O
has O
a O
transcriptionally O
activated O
u B
- I
PAR I
gene I
, O
and O
the O
other O
( O
GEO O
) O
overexpresses O
the O
receptor O
only O
after O
phorbol O
ester O
treatment O
. O

The O
expression O
pattern O
of O
the O
reporter O
gene O
was O
compared O
to O
that O
of O
the O
endogenous B
PDGFbeta I
r I
gene I
. O

The O
two O
SH3 B
domains I
are O
separated O
by O
a O
54 O
amino O
acid O
linker O
region O
, O
whose O
length O
is O
highly O
conserved O
in O
xenopus O
, O
chicken O
, O
and O
mamalian B
Crk I
II I
proteins I
. O

The O
fz B
- I
1 I
and O
fz B
- I
2 I
genes I
are O
widely O
expressed O
in O
rat O
tissues O
with O
the O
highest O
steady O
- O
state O
levels O
of O
mRNA O
in O
kidney O
, O
liver O
, O
heart O
, O
uterus O
, O
and O
ovary O
. O

In O
this O
report O
, O
we O
establish O
that O
the O
heteromeric O
CCAAT B
- I
binding I
factor I
CBF B
is O
the O
major O
component O
of O
the O
C1 B
- I
binding I
factor I
( O
C1F B
) O
in O
human O
cells O
. O

In O
this O
report O
, O
we O
establish O
that O
the O
heteromeric O
CCAAT B
- I
binding I
factor I
CBF B
is O
the O
major O
component O
of O
the O
C1 B
- I
binding I
factor I
( O
C1F B
) O
in O
human O
cells O
. O

The O
human O
RFC B
- I
1 I
gene I
differs O
from O
the O
mouse O
and O
hamster O
genes O
both O
in O
terms O
of O
the O
total O
number O
of O
exons O
and O
in O
regard O
to O
alternatives O
of O
exon O
1 O
which O
encode O
5 O
' O
end O
heterogeneity O
. O

Our O
Northern O
and O
Southern O
blot O
analyses O
of O
meningiomas O
clearly O
suggest O
the O
CLH B
- I
22 I
gene I
may O
be O
involved O
in O
the O
tumor O
development O
and O
can O
be O
considered O
as O
a O
candidate O
for O
a O
tumor O
suppressor O
. O

In O
this O
report O
, O
we O
demonstrate O
that O
FRS2 B
forms O
a O
complex O
with O
the O
N B
- I
terminal I
SH2 I
domain I
of O
the O
protein B
tyrosine I
phosphatase I
Shp2 I
in O
response O
to O
FGF B
stimulation O
. O

Joint O
ultrasonography O
demonstrating O
thickening O
of O
synoviae O
and O
tendons O
has O
become O
a O
useful O
non O
- O
invasive O
diagnostic O
tool O
, O
although O
it O
is O
not O
specific O
for O
beta B
2 I
- I
M I
amyloidosis O
, O
and O
results O
depend O
on O
observer O
experience O
. O

Immunofluorescence O
tests O
for O
Borrelia B
burgdorferi I
serum I
antibodies I
had O
positive O
results O
, O
but O
G O
- O
penicillin O
treatment O
was O
ineffective O
. O

The O
herpesvirus B
entry I
mediator I
C I
( O
HveC B
) O
, O
previously O
known O
as O
poliovirus B
receptor I
- I
related I
protein I
1 I
( O
PRR1 B
) O
, O
and O
the O
herpesvirus B
Ig I
- I
like I
receptor I
( O
HIgR B
) O
are O
the O
bona O
fide O
receptors O
employed O
by O
herpes O
simplex O
virus O
- O
1 O
and O
- O
2 O
( O
HSV O
- O
1 O
and O
- O
2 O
) O
for O
entry O
into O
the O
human O
cell O
lines O
most O
frequently O
used O
in O
HSV O
studies O
. O

The O
combination O
of O
ICP47 B
and O
US11 B
rendered O
fibroblasts O
negative O
for O
surface B
class I
I I
MHC I
and O
allowed O
a O
class B
I I
MHC I
- O
low O
population O
of O
T O
cells O
to O
be O
sorted O
by O
flow O
cytometry O
. O

In O
addition O
, O
we O
mapped O
a O
putative O
hnRNP B
A1 I
binding I
site I
in O
U5 B
RNA I
and O
demonstrated O
that O
p40CRS B
( O
hnRNP B
A1 I
) O
binding O
to O
that O
site O
correlates O
with O
CRS B
function O
. O

This O
element O
was O
required O
for O
both O
basal O
and O
activated O
expression O
and O
almost O
certainly O
functions O
as O
a O
TATA B
- I
binding I
protein I
interaction O
site O
. O

In O
HepG2 O
cells O
, O
SREBP B
- I
1c I
mRNA I
and O
precursor O
protein O
levels O
were O
induced O
by O
treatment O
with O
22 O
( O
R O
) O
- O
hydroxycholesterol O
and O
9 O
- O
cis O
- O
retinoic O
acid O
, O
confirming O
that O
endogenous O
LXR B
- O
RXR B
activation O
can O
induce O
endogenous B
SREBP I
- I
1c I
expression O
. O

In O
HepG2 O
cells O
, O
SREBP B
- I
1c I
mRNA I
and O
precursor O
protein O
levels O
were O
induced O
by O
treatment O
with O
22 O
( O
R O
) O
- O
hydroxycholesterol O
and O
9 O
- O
cis O
- O
retinoic O
acid O
, O
confirming O
that O
endogenous O
LXR B
- O
RXR B
activation O
can O
induce O
endogenous B
SREBP I
- I
1c I
expression O
. O

Here O
, O
we O
analyzed O
the O
interaction O
of O
CYT B
- I
18 I
with O
a O
small O
RNA O
( O
P4 B
- I
P6 I
RNA I
) O
corresponding O
to O
the O
isolated O
P4 B
- I
P6 I
domain I
of O
the O
N B
. I
crassa I
mitochondrial I
large I
subunit I
ribosomal I
RNA I
intron I
. O

Here O
, O
we O
analyzed O
the O
interaction O
of O
CYT B
- I
18 I
with O
a O
small O
RNA O
( O
P4 B
- I
P6 I
RNA I
) O
corresponding O
to O
the O
isolated O
P4 B
- I
P6 I
domain I
of O
the O
N B
. I
crassa I
mitochondrial I
large I
subunit I
ribosomal I
RNA I
intron I
. O

Transcriptional O
analysis O
indicates O
that O
human B
TBP I
functions O
poorly O
at O
promoters O
recognized O
by O
RNA B
polymerases I
I I
and I
III I
and O
at O
RNA B
Pol I
II I
promoters I
lacking O
a O
conventional O
TATA O
element O
. O

Our O
results O
separate O
these O
factors O
into O
four O
regulatory O
classes O
: O
( O
i O
) O
constitutive O
factors O
, O
such O
as O
Oct B
- I
1 I
and O
probably O
Sp1 B
, O
that O
are O
expressed O
in O
thymocytes O
at O
all O
stages O
; O
( O
ii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
kappa I
B I
and O
complexes O
binding O
to O
the O
region O
of O
a O
CD28 B
response I
element I
, O
that O
can O
be O
activated O
in O
all O
thymocytes O
, O
including O
those O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
that O
can O
undergo O
selection O
; O
( O
iii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
AT I
and O
AP B
- I
1 I
, O
that O
can O
be O
activated O

We O
also O
show O
that O
in O
fusions O
with O
the O
DNA O
binding O
domain O
of O
GAL4 B
, O
full O
activity O
requires O
the O
entire O
BHV B
- I
alpha I
TIF I
, O
although O
both O
amino O
and O
carboxyl O
termini O
display O
some O
activity O
on O
their O
own O
. O

We O
examined O
the O
contribution O
of O
the O
M B
- I
MuLV I
enhancers I
to O
the O
transcriptional O
activity O
and O
pathogenesis O
of O
M O
- O
MuLV O
by O
constructing O
LTRs O
containing O
heterologous O
enhancer O
elements O
. O

Mutations O
in O
the O
beta B
- I
galactosidase I
gene I
result O
in O
the O
lysosomal O
storage O
disorders O
GM1 O
- O
gangliosidosis O
and O
Morquio O
B O
syndrome O
. O

We O
have O
generated O
transgenic O
fly O
strains O
with O
mutations O
affecting O
specific O
TRA B
- I
2 I
isoforms I
to O
investigate O
their O
individual O
roles O
in O
regulating O
the O
alternative O
processing O
of O
doublesex B
, O
exuperantia B
and O
tra B
- I
2 I
pre I
- I
mRNA I
. O

The O
IR4 O
ORF O
exhibits O
significant O
homology O
to O
the O
immediate B
- I
early I
gene I
US1 B
( O
ICP22 B
) O
of O
herpes O
simplex O
virus O
type O
1 O
and O
to O
the O
ICP22 B
homologs O
of O
varicella O
- O
zoster O
virus O
( O
ORF63 B
) O
, O
pseudorabies O
virus O
( O
RSp40 B
) O
, O
and O
equine O
herpesvirus O
4 O
( O
ORF4 O
) O
. O

CrkII B
and O
CrkL B
constitutively O
formed O
complex O
with O
the O
guanine B
nucleotide I
exchange I
factor I
C3G B
, O
in O
unstimulated O
as O
well O
as O
PDGF B
- O
stimulated O
cells O
. O

In O
further O
support O
of O
the O
biological O
significance O
of O
these O
DNA O
- O
protein O
interactions O
, O
the O
IL2RA B
oligonucleotide O
from O
- O
291 O
to O
- O
245 O
proved O
to O
be O
sufficient O
in O
either O
orientation O
to O
confer O
PMA O
inducibility O
to O
the O
mitogen O
- O
insensitive O
thymidine B
kinase I
gene I
promoter I
in O
Jurkat O
cells O
. O

Computer O
analysis O
revealed O
that O
the O
human B
protein I
P1 I
sequence I
corresponding O
to O
amino O
acid O
residues O
within O
the O
N O
- O
terminal O
RNA O
binding O
domain O
displays O
high O
homology O
( O
greater O
than O
54 O
% O
identity O
; O
61 O
to O
94 O
% O
similarity O
) O
with O
two O
animal O
virus O
proteins O
which O
possess O
RNA O
binding O
activity O
( O
vaccinia B
virus I
E3L I
; O
rotavirus B
VP2 I
) O
and O
two O
proteins O
of O
unknown O
function O
( O
murine B
TIK I
; O
rotavirus B
NS34 I
) O
, O
but O
which O
are O
likely O
RNA O
binding O
proteins O
. O

There O
was O
a O
highly O
significant O
decrease O
in O
serum B
eosinophil I
cationic I
protein I
in O
patients O
with O
elevated O
AGA B
. O

Presently O
, O
we O
made O
chain O
pair O
switch O
, O
chimeric O
, O
and O
site O
mutant B
gamma I
delta I
TCRs I
and O
transfected O
them O
into O
TCR O
- O
mutant O
Jurkat O
T O
cells O
to O
examine O
the O
effects O
of O
changing O
the O
TCR B
gamma I
junctional I
region I
sequences I
on O
reactivity O
to O
prenyl B
pyrophosphate I
Ags I
. O

Activated B
Ki I
- I
Ras I
suppresses O
12 O
- O
O O
- O
tetradecanoylphorbol O
- O
13 O
- O
acetate O
- O
induced O
activation O
of O
the O
c B
- I
Jun I
NH2 I
- I
terminal I
kinase I
pathway I
in O
human O
colon O
cancer O
cells O
. O

Also O
, O
anti B
- I
HIV I
gp120 I
and O
anti B
- I
CD4 I
crosslinking O
induced O
a O
10 O
- O
15 O
- O
fold O
increase O
in O
levels O
of O
both O
PI B
3 I
- I
and I
PI I
4 I
- I
kinase I
activity O
in O
anti B
- I
CD4 I
precipitates O
. O

One O
of O
the O
ORFs O
in O
the O
Methanococcus O
jannaschii O
genome O
possesses O
high O
similarity O
to O
the O
M B
. I
aeolicus I
ilvB I
, O
indicating O
that O
it O
is O
an O
authentic O
AHAS B
. O

Kinase O
renaturation O
tests O
designed O
to O
detect O
reactivated O
protein O
kinases O
after O
electrophoresis O
in O
sodium O
dodecyl O
sulfate O
- O
polyacrylamide O
gels O
revealed O
the O
presence O
of O
a O
60 O
- O
kDa O
kinase O
in O
the O
washed O
immunoprecipitate O
obtained O
from O
liver O
cytosol O
using O
anti B
- I
AHR I
antibody I
( O
IgG B
) O
and O
protein O
A O
/ O
G O
/ O
agarose O
beads O
but O
not O
when O
a O
nonspecific O
IgG B
was O
used O
instead O
of O
anti B
- I
AHR I
antibody I
. O

Kinase O
renaturation O
tests O
designed O
to O
detect O
reactivated O
protein O
kinases O
after O
electrophoresis O
in O
sodium O
dodecyl O
sulfate O
- O
polyacrylamide O
gels O
revealed O
the O
presence O
of O
a O
60 O
- O
kDa O
kinase O
in O
the O
washed O
immunoprecipitate O
obtained O
from O
liver O
cytosol O
using O
anti B
- I
AHR I
antibody I
( O
IgG B
) O
and O
protein O
A O
/ O
G O
/ O
agarose O
beads O
but O
not O
when O
a O
nonspecific O
IgG B
was O
used O
instead O
of O
anti B
- I
AHR I
antibody I
. O

DESIGN O
: O
Activating B
protein I
- I
1 I
( O
AP B
- I
1 I
) O
and O
Tat B
- O
induced O
transcription O
were O
assessed O
using O
Jun B
and O
hybrid O
Tat B
/ O
Jun B
- O
expression O
plasmids O
and O
reporter O
gene O
constructs O
which O
contained O
AP B
- I
1 I
binding I
sites I
upstream O
of O
the O
rat B
prolactin I
TATAA I
element I
or O
an O
HIV B
- I
1 I
LTR I
construct I
in O
which O
AP B
- I
1 I
binding I
sites I
replaced O
the O
TAR O
element O
. O

DESIGN O
: O
Activating B
protein I
- I
1 I
( O
AP B
- I
1 I
) O
and O
Tat B
- O
induced O
transcription O
were O
assessed O
using O
Jun B
and O
hybrid O
Tat B
/ O
Jun B
- O
expression O
plasmids O
and O
reporter O
gene O
constructs O
which O
contained O
AP B
- I
1 I
binding I
sites I
upstream O
of O
the O
rat B
prolactin I
TATAA I
element I
or O
an O
HIV B
- I
1 I
LTR I
construct I
in O
which O
AP B
- I
1 I
binding I
sites I
replaced O
the O
TAR O
element O
. O

One O
day O
postoperatively O
, O
the O
mononuclear O
leukocyte O
beta B
2 I
- I
receptor I
density O
decreased O
maximally O
by O
45 O
+ O
/ O
- O
11 O
% O
in O
the O
enflurane O
patients O
, O
and O
by O
53 O
+ O
/ O
- O
6 O
% O
in O
the O
neurolept O
patients O
. O

When O
expressed O
in O
Escherichia O
coli O
, O
SH B
- I
PTP2 I
displays O
tyrosine B
- I
specific I
phosphatase I
activity O
. O

The O
biological O
activity O
of O
these O
mutants O
was O
tested O
by O
determining O
their O
capacity O
to O
( O
i O
) O
reconstitute O
RNA B
polymerase I
activity O
in O
vivo O
by O
cotransfection O
with O
proteins O
NP B
, O
PB1 B
, O
and O
PA B
and O
a O
virion O
- O
like O
RNA O
encoding O
the O
cat B
gene O
into O
vaccinia O
virus O
T7 O
- O
infected O
COS O
- O
1 O
cells O
and O
( O
ii O
) O
complete O
with O
the O
wild B
- I
type I
PB2 I
activity O
. O

Western O
blot O
analyses O
reveals O
that O
cJun B
and O
the O
C B
/ I
EBP I
family I
member I
C B
/ I
EBP I
- I
beta I
are O
physiologically O
relevant O
transcription O
factors O
whose O
expression O
corresponds O
with O
mda B
- I
7 I
mRNA I
expression O
. O

In O
isolated O
olfactory O
cilia O
certain O
odorants O
elicit O
a O
rapid O
and O
transient O
cAMP O
response O
, O
terminated O
by O
a O
concerted O
process O
which O
requires O
the O
action O
of O
two O
protein O
kinases O
, O
protein B
kinase I
A I
( O
PKA B
) O
and O
a O
receptor B
- I
specific I
kinase I
( O
GRK3 B
) O
( O
Schleicher O
, O
S O
. O
, O
Boekhoff O
, O
I O
. O

Acetyl B
- I
CoA I
carboxylase I
from O
yeast O
is O
an O
essential O
enzyme O
and O
is O
regulated O
by O
factors O
that O
control O
phospholipid O
metabolism O
. O

However O
, O
the O
sequence O
of O
mRAR B
- I
beta I
3 I
region I
A I
differs O
from O
that O
of O
mRAR B
- I
beta I
1 I
by O
an O
additional O
27 O
C O
- O
terminal O
amino O
acids O
encoded O
in O
an O
81 O
nucleotide O
- O
long O
putative O
exon O
which O
is O
spliced O
in O
between O
the O
exons O
encoding O
the O
A B
and I
B I
regions I
of I
mRAR I
- I
beta I
1 I
. O

The O
3 O
' O
region O
of O
the O
transcript O
contained O
a O
fully O
conserved O
, O
correctly O
spliced O
TCR B
alpha I
C I
region I
which O
was O
polyadenylated O
at O
the O
3 O
' O
end O
. O

CONCLUSIONS O
: O
These O
results O
suggest O
that O
histamine B
- I
2 I
receptor I
activation O
mechanisms O
may O
not O
be O
involved O
in O
postoperative O
IL B
- I
6 I
synthesis O
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine B
proteases I
, O
in O
particular O
the O
trypsin B
- I
like I
proteases I
, O
members O
of O
the O
glandular B
kallikrein I
family I
( O
including O
prostate B
- I
specific I
antigen I
, O
nerve B
growth I
factor I
gamma I
, O
and O
epidermal B
growth I
factor I
- I
binding I
protein I
) O
and O
the O
activators O
for O
the O
kringle B
family I
proteins I
( O
including O
the O
human B
tissue I
plasminogen I
activator I
and O
human B
hepatocyte I
growth I
factor I
activator I
) O
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine B
proteases I
, O
in O
particular O
the O
trypsin B
- I
like I
proteases I
, O
members O
of O
the O
glandular B
kallikrein I
family I
( O
including O
prostate B
- I
specific I
antigen I
, O
nerve B
growth I
factor I
gamma I
, O
and O
epidermal B
growth I
factor I
- I
binding I
protein I
) O
and O
the O
activators O
for O
the O
kringle B
family I
proteins I
( O
including O
the O
human B
tissue I
plasminogen I
activator I
and O
human B
hepatocyte I
growth I
factor I
activator I
) O
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine B
proteases I
, O
in O
particular O
the O
trypsin B
- I
like I
proteases I
, O
members O
of O
the O
glandular B
kallikrein I
family I
( O
including O
prostate B
- I
specific I
antigen I
, O
nerve B
growth I
factor I
gamma I
, O
and O
epidermal B
growth I
factor I
- I
binding I
protein I
) O
and O
the O
activators O
for O
the O
kringle B
family I
proteins I
( O
including O
the O
human B
tissue I
plasminogen I
activator I
and O
human B
hepatocyte I
growth I
factor I
activator I
) O
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine B
proteases I
, O
in O
particular O
the O
trypsin B
- I
like I
proteases I
, O
members O
of O
the O
glandular B
kallikrein I
family I
( O
including O
prostate B
- I
specific I
antigen I
, O
nerve B
growth I
factor I
gamma I
, O
and O
epidermal B
growth I
factor I
- I
binding I
protein I
) O
and O
the O
activators O
for O
the O
kringle B
family I
proteins I
( O
including O
the O
human B
tissue I
plasminogen I
activator I
and O
human B
hepatocyte I
growth I
factor I
activator I
) O
. O

We O
established O
that O
, O
in O
unstimulated O
lymphocytes O
, O
the O
Src B
homology I
2 I
( O
SH2 B
) O
and O
SH3 B
domain I
- I
containing I
protein I
Grb2 B
and O
the O
p85 B
subunit O
of O
phosphatidylinositol B
3 I
- I
kinase I
, O
associate O
constitutively O
with O
Cbl B
via O
their O
SH3 B
domains I
. O

Expression O
of O
the O
Hox B
genes I
egl B
- I
5 I
and O
mab B
- I
5 I
is O
reduced O
in O
lin B
- I
49 I
and O
lin B
- I
59 I
mutants I
, O
suggesting O
lin B
- I
49 I
and O
lin B
- I
59 I
regulate O
HOM B
- I
C I
gene I
expression O
in O
C O
. O
elegans O
as O
the O
trx B
- I
G I
genes I
do O
in O
Drosophila O
. O

Expression O
of O
the O
Hox B
genes I
egl B
- I
5 I
and O
mab B
- I
5 I
is O
reduced O
in O
lin B
- I
49 I
and O
lin B
- I
59 I
mutants I
, O
suggesting O
lin B
- I
49 I
and O
lin B
- I
59 I
regulate O
HOM B
- I
C I
gene I
expression O
in O
C O
. O
elegans O
as O
the O
trx B
- I
G I
genes I
do O
in O
Drosophila O
. O

Expression O
of O
the O
Hox B
genes I
egl B
- I
5 I
and O
mab B
- I
5 I
is O
reduced O
in O
lin B
- I
49 I
and O
lin B
- I
59 I
mutants I
, O
suggesting O
lin B
- I
49 I
and O
lin B
- I
59 I
regulate O
HOM B
- I
C I
gene I
expression O
in O
C O
. O
elegans O
as O
the O
trx B
- I
G I
genes I
do O
in O
Drosophila O
. O

lin B
- I
49 I
and O
lin B
- I
59 I
transgenes I
are O
expressed O
widely O
throughout O
C O
. O
elegans O
animals O
. O

Antiserum O
raised O
against O
rat B
liver I
S6 I
kinase I
specifically O
immunoprecipitates O
the O
purified O
32P O
- O
labeled O
H4 O
hepatoma O
insulin O
- O
stimulated O
S6 B
kinase I
. O

The O
other O
end O
of O
this O
cluster O
contained O
the O
human B
type I
I I
cytokeratin I
K20 B
and O
K12 B
gene I
loci O
. O

A O
physical O
and O
genetic O
map O
covering O
the O
entire O
RP12 B
candidate I
gene I
region I
was O
constructed O
. O

The O
single O
copy O
flotillin B
- I
1 I
gene I
is O
located O
at O
6p21 O
. O
3 O
in O
the O
MHC B
class I
I I
region I
and O
consists O
of O
13 O
exons O
over O
15 O
kb O
. O

The O
single O
copy O
flotillin B
- I
1 I
gene I
is O
located O
at O
6p21 O
. O
3 O
in O
the O
MHC B
class I
I I
region I
and O
consists O
of O
13 O
exons O
over O
15 O
kb O
. O

The O
in O
vivo O
response O
of O
the O
PacC B
- I
like I
decamers I
to O
external O
pH O
was O
dependent O
on O
the O
status O
of O
the O
pH O
- O
regulated O
activator O
YlRim101p B
, O
which O
is O
homologous O
to O
the O
A O
. O
nidulans O
PacC B
regulator O
. O

Northern O
blot O
analysis O
identified O
retina O
- O
specific O
transcripts O
of O
3 O
. O
0 O
kb O
for O
rod B
G I
alpha I
t I
and O
2 O
. O
6 O
kb O
for O
cone B
G I
alpha I
t I
. O

Northern O
blot O
analysis O
identified O
retina O
- O
specific O
transcripts O
of O
3 O
. O
0 O
kb O
for O
rod B
G I
alpha I
t I
and O
2 O
. O
6 O
kb O
for O
cone B
G I
alpha I
t I
. O

Importantly O
, O
a O
single O
base O
change O
in O
the O
fifth O
position O
of O
the O
c B
- I
fos I
sequence I
( O
GGTCTnnnAGACC O
to O
GGTCA O
/ O
GnnnAGACC O
) O
produced O
an O
element O
that O
bound O
the O
estrogen B
receptor I
and O
conferred O
estrogen O
- O
dependent O
transcriptional O
activation O
of O
a O
reporter O
gene O
. O

1 O
. O
23 O
) O
as O
a O
PPARalpha B
- I
interacting I
protein I
. O

The O
deduced O
amino O
- O
acid O
sequence O
of O
the O
mature O
enzyme O
showed O
very O
low O
homology O
( O
< O
20 O
. O
4 O
% O
identity O
) O
to O
those O
of O
known O
pectinolytic O
enzymes O
in O
the O
large O
pectate B
lyase I
superfamily I
( O
the O
polysaccharide B
lyase I
family I
1 I
) O
. O

Incubation O
of O
HeLa O
cell O
cytoplasmic O
extracts O
with O
a O
purified O
recombinant O
glutathione B
S I
- I
transferase I
- O
raf B
fusion O
protein O
in O
the O
presence O
of O
ATP O
released O
active O
NF B
- I
kappa I
B I
that O
could O
be O
detected O
by O
electrophoretic O
gel O
mobility O
shift O
assay O
. O

Incubation O
of O
HeLa O
cell O
cytoplasmic O
extracts O
with O
a O
purified O
recombinant O
glutathione B
S I
- I
transferase I
- O
raf B
fusion O
protein O
in O
the O
presence O
of O
ATP O
released O
active O
NF B
- I
kappa I
B I
that O
could O
be O
detected O
by O
electrophoretic O
gel O
mobility O
shift O
assay O
. O

The O
predicted O
vav B
oncogene I
protein I
sequence I
exhibits O
several O
motifs O
reminiscent O
of O
transcriptional O
factors O
. O

Hepatitis B
B I
immune I
globulins I
and O
HIV B
antibodies I
. O

Successive O
5 O
' O
deletions O
of O
the O
[ O
- O
326 O
; O
+ O
20 O
] O
type B
II I
sPLA2 I
promoter I
indicated O
that O
the O
region O
upstream O
of O
position O
- O
195 O
inhibits O
the O
transcription O
activity O
sixfold O
in O
HepG2 O
cells O
but O
not O
in O
HeLa O
cells O
. O

E1A B
+ O
cHa B
- I
ras I
transformed O
rat O
embryo O
fibroblast O
cells O
are O
characterized O
by O
high O
and O
constitutive O
DNA O
binding O
activities O
of O
AP B
- I
1 I
dimers I
with O
significantly O
altered O
composition O
. O

They O
are O
both O
insensitive O
to O
inhibitors O
of O
serine B
and I
aspartyl I
proteinases I
but O
are O
sensitive O
to O
sulfhydryl O
reagents O
and O
0 O
. O
5 O
mM O
ZnCl2 O
. O

In O
this O
study O
, O
we O
verified O
that O
PI B
3 I
- I
kinase I
associates O
with O
the O
CD4 B
: O
p56lck B
complex I
as O
judged O
by O
the O
presence O
of O
PI O
3 O
- O
phosphate O
generated O
from O
anti B
- I
CD4 I
immunoprecipitates O
and O
detected O
by O
high O
- O
pressure O
liquid O
chromatographic O
analysis O
. O

In O
this O
study O
, O
a O
site O
of O
PDGF B
- O
induced O
tyrosine O
phosphorylation O
was O
mapped O
to O
Tyr O
138 O
in O
the O
SH3 B
domain I
; O
Tyr O
138 O
is O
exposed O
on O
the O
SH3 B
peptide I
binding I
surface I
. O

C B
/ I
EBP I
delta I
( O
NFIL B
- I
6 I
beta I
) O
was O
not O
detected O
in O
complexes O
utilizing O
extracts O
from O
the O
IL B
- I
1 I
nonproducing O
T O
cell O
line O
. O

C B
/ I
EBP I
delta I
( O
NFIL B
- I
6 I
beta I
) O
was O
not O
detected O
in O
complexes O
utilizing O
extracts O
from O
the O
IL B
- I
1 I
nonproducing O
T O
cell O
line O
. O

Recently O
, O
we O
and O
other O
laboratories O
have O
identified O
a O
family O
of O
caveolin B
- I
related I
proteins I
; O
caveolin B
has O
been O
re O
- O
termed O
caveolin B
- I
1 I
. O

Role O
of O
zinc B
- I
finger I
proteins I
Sp1 I
and O
zif268 B
/ O
egr B
- I
1 I
in O
transcriptional O
regulation O
of O
the O
human B
synaptobrevin I
II I
gene I
. O

First O
, O
mutations O
in O
the O
IFNgamma B
- I
activated I
sequence I
( O
GAS B
) O
, O
either O
multimerized O
or O
in O
the O
context O
of O
the O
1 B
. I
7 I
- I
kb I
IRF I
- I
1 I
promoter I
, O
failed O
to O
mediate O
a O
PRL B
response O
, O
showing O
that O
the O
IRF B
- I
1 I
GAS B
is O
a O
target O
of O
PRL B
signaling O
. O

AU O
- O
rich O
elements O
in O
the O
3 O
' O
- O
untranslated O
region O
of O
a O
new O
mucin B
- I
type I
gene I
family O
of O
Trypanosoma O
cruzi O
confers O
mRNA O
instability O
and O
modulates O
translation O
efficiency O
. O

In O
the O
Saccharomyces B
cerevisiae I
actin I
intron I
a O
silent O
branch O
point O
- O
like O
sequence O
( O
UACUAAG O
) O
is O
located O
7 O
nt O
upstream O
of O
the O
canonical O
sequence O
. O

trans O
- O
activation O
of O
the O
HIV B
- I
1 I
LTR I
by O
the O
HIV B
- I
1 I
Tat I
and O
HTLV B
- I
I I
Tax I
proteins I
is O
mediated O
by O
different O
cis O
- O
acting O
sequences O
. O

trans O
- O
activation O
of O
the O
HIV B
- I
1 I
LTR I
by O
the O
HIV B
- I
1 I
Tat I
and O
HTLV B
- I
I I
Tax I
proteins I
is O
mediated O
by O
different O
cis O
- O
acting O
sequences O
. O

This O
result O
, O
together O
with O
the O
fact O
that O
unrearranged B
V I
kappa I
genes I
are O
transcriptionally O
silent O
, O
suggests O
that O
structural O
features O
of O
both O
the O
V B
kappa I
and O
C B
kappa I
loci I
contribute O
to O
the O
overall O
transcriptional O
efficiency O
of O
a O
rearranged B
V I
kappa I
- I
C I
kappa I
gene I
. O

VLA B
- I
4 I
integrin I
cross O
- O
linking O
on O
human O
monocytic O
THP O
- O
1 O
cells O
induces O
tissue O
factor O
expression O
by O
a O
mechanism O
involving O
mitogen B
- I
activated I
protein I
kinase I
. O

Protein B
kinase I
C I
( O
PKC B
) O
activation O
after O
treatment O
of O
human O
neuroblastoma O
SK O
- O
N O
- O
BE O
( O
2 O
) O
C O
cells O
with O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
was O
found O
to O
enhance O
transcription O
of O
the O
human O
dopamine B
beta I
- I
hydroxylase I
( O
DBH B
) O
in O
those O
cells O
. O

Bedbug O
( O
Cimex O
lectularius O
) O
samples O
adult O
and O
nymphs O
either O
engorged O
or O
starved O
from O
Central O
Security O
Forces O
sleeping O
wards O
, O
laboratory O
animal O
house O
and O
control O
samples O
from O
laboratory O
reared O
colonies O
were O
ground O
and O
subjected O
to O
ELISA O
test O
of O
hepatitis B
B I
surface I
antigen I
together O
with O
276 O
serum O
samples O
from O
the O
recruits O
slept O
in O
those O
wards O
. O

Thus O
, O
BCR B
ligation O
initiates O
a O
PI B
3 I
- I
kinase I
/ O
Akt B
/ O
GSK B
- I
3 I
signaling O
pathway O
. O

In O
contrast O
SF B
, O
but O
not O
GM B
- I
CSF I
or O
IL B
- I
3 I
, O
induced O
tyrosine O
phosphorylation O
of O
phospholipase B
C I
- I
gamma I
( O
PLC B
- I
gamma I
) O
. O

Replacement O
of O
Val20 O
- O
Leu21 O
with O
Ala O
- O
Ala O
produced O
a O
dimeric B
RII I
beta I
protein I
that O
binds O
AKAP75 B
approximately O
4 O
% O
as O
avidly O
as O
wild B
- I
type I
RII I
beta I
. O

cDNA O
cloning O
reveals O
two O
mouse B
beta5 I
integrin I
transcripts I
distinct O
in O
cytoplasmic O
domains O
as O
a O
result O
of O
alternative O
splicing O
. O

Thus O
, O
the O
mutants O
are O
deficient O
in O
production O
of O
the O
O B
- I
antigen I
polymerase I
and O
were O
termed O
rfc B
mutants I
. O

The O
SEC27 B
gene I
was O
cloned O
, O
and O
the O
sequence O
predicts O
a O
99 O
. O
4 O
- O
kDa O
protein O
with O
45 O
% O
sequence O
identity O
to O
mammalian O
beta B
' I
- I
COP I
. O

The O
promoter O
for O
HMG B
- I
CoA I
synthase I
contains O
two O
binding O
sites O
for O
the O
sterol B
regulatory I
element I
- I
binding I
proteins I
( O
SREBPs B
) O
. O

p27 B
( O
Kip1 B
) O
is O
a O
member O
of O
the O
Cip B
- O
Kip B
family O
of O
cyclin B
- I
dependent I
kinase I
( O
Cdk B
) O
inhibitors O
that O
binds O
to O
cyclin B
- O
Cdk B
complexes O
and O
inhibits O
their O
catalytic O
activity O
in O
response O
to O
antiproliferative O
stimuli O
. O

Toxicity O
of O
benzoyl O
chloride O
( O
2 O
, O
4 O
, O
6 O
- O
trichlorophenyl O
) O
hydrazone O
( O
Banamite O
) O
and O
potential O
metabolites O
to O
twospotted O
spider O
mites O
and O
potency O
as O
inhibitors O
of O
rat B
liver I
monoamine I
oxidase I
. O

Immunoprecipitation O
of O
spinophilin B
or O
neurabin B
from O
crude O
brain O
extracts O
selectively O
coprecipitated O
PP1gamma B
( I
1 I
) I
over O
PP1beta B
. O

Taken O
together O
, O
these O
results O
indicate O
that O
ICSBP B
and O
PU B
. I
1 I
are O
critical O
elements O
for O
IL B
- I
18 I
gene I
expression O
. O

Transient O
transfection O
assays O
indicated O
that O
the O
( O
- O
4551 O
) O
UCP1 B
- O
CAT B
construct O
, O
containing O
the O
5 O
' O
- O
regulatory O
region O
of O
the O
rat B
ucp I
- I
1 I
gene I
, O
was O
activated O
by O
PPARalpha B
co O
- O
transfection O
in O
a O
dose O
- O
dependent O
manner O
and O
this O
activation O
was O
potentiated O
by O
Wy O
14 O
, O
643 O
and O
retinoid B
X I
receptor I
alpha I
. O

Furthermore O
, O
agonist O
action O
at O
a O
5 B
- I
HT1 I
receptor I
and O
antagonist O
action O
at O
5 B
- I
HT2 I
receptors I
both O
appear O
to O
contribute O
to O
antidepressant O
- O
like O
activity O
on O
the O
DRL O
72 O
- O
s O
schedule O
. O

Furthermore O
, O
agonist O
action O
at O
a O
5 B
- I
HT1 I
receptor I
and O
antagonist O
action O
at O
5 B
- I
HT2 I
receptors I
both O
appear O
to O
contribute O
to O
antidepressant O
- O
like O
activity O
on O
the O
DRL O
72 O
- O
s O
schedule O
. O

MsEPV O
genes O
with O
putative O
functions O
in O
prevention O
and O
repair O
of O
DNA O
damage O
include O
a O
complete O
base O
excision O
repair O
pathway O
( O
uracil B
DNA I
glycosylase I
, O
AP B
endonuclease I
, O
DNA B
polymerase I
beta I
, O
and O
an O
NAD B
+ I
- I
dependent I
DNA I
ligase I
) O
, O
a O
photoreactivation O
repair O
pathway O
( O
cyclobutane B
pyrimidine I
dimer I
photolyase I
) O
, O
a O
LINE B
- I
type I
reverse I
transcriptase I
, O
and O
a O
mutT B
homologue I
. O

Partial O
characterization O
of O
the O
CCAAT O
box O
in O
the O
promoter O
of O
the O
hLGFBP B
- I
1 I
gene I
: O
interaction O
with O
negatively O
acting O
transcription O
factors O
in O
decidualized O
human O
endometrial O
stromal O
cells O
. O

A O
role O
for O
phosphatidylinositol B
3 I
- I
kinase I
in O
the O
regulation O
of O
beta B
1 I
integrin I
activity O
by O
the O
CD2 B
antigen O
. O

In O
each O
of O
the O
studied O
HPV O
types O
, O
the O
two O
CDP B
/ O
Cut B
binding O
sites O
of O
PSM B
overlap O
with O
the O
known O
or O
presumed O
binding O
sites O
of O
the O
replication B
initiator I
protein I
E1 I
. O

The O
classic O
sterol O
regulatory O
cis O
element O
( O
sre O
- O
1 O
) O
in O
the O
LDL B
receptor I
promoter O
mediates O
sterol B
regulatory I
element I
binding I
protein I
( O
SREBP B
) O
- O
binding O
and O
the O
effects O
of O
insulin B
and O
platelet B
derived I
growth I
factor I
( O
PDGF B
) O
. O

AIMS O
: O
We O
postulated O
that O
perhexiline O
, O
a O
novel O
anti O
- O
ischaemic O
agent O
with O
an O
oxygen O
- O
sparing O
metabolic O
effect O
in O
the O
myocardium O
( O
via O
inhibition O
of O
carnitine B
palmitoyltransferase I
- I
1 I
) O
and O
no O
adverse O
haemodynamic O
effects O
, O
may O
improve O
symptomatic O
status O
in O
elderly O
patients O
with O
severe O
aortic O
stenosis O
. O

The O
IFNAR B
chain I
interacts O
with O
both O
IFN B
- I
alpha I
2 I
and O
IFN B
- I
beta I
, O
as O
demonstrated O
by O
cross O
- O
linking O
. O

To O
clone O
cDNAs O
for O
the O
beta O
subunit O
of O
rabbit B
eIF I
- I
2B I
, O
amino O
acid O
sequence O
data O
was O
first O
obtained O
and O
used O
to O
design O
redundant O
oligonucleotide O
primers O
for O
use O
in O
PCR O
. O

The O
promyelocytic B
leukemia I
protein I
interacts O
with O
Sp1 B
and O
inhibits O
its O
transactivation O
of O
the O
epidermal B
growth I
factor I
receptor I
promoter O
. O

Here O
we O
report O
that O
point O
mutations O
of O
the O
Abd B
- I
B I
gene I
in O
trans O
suppress O
the O
Fab B
- I
7 I
phenotype I
in O
a O
pairing O
- O
dependent O
manner O
and O
thus O
represent O
a O
type O
of O
transvection O
. O

Here O
we O
report O
that O
point O
mutations O
of O
the O
Abd B
- I
B I
gene I
in O
trans O
suppress O
the O
Fab B
- I
7 I
phenotype I
in O
a O
pairing O
- O
dependent O
manner O
and O
thus O
represent O
a O
type O
of O
transvection O
. O

The O
cloning O
of O
human B
apo I
B I
- I
100 I
has O
provided O
new O
insights O
into O
the O
structure O
and O
physicochemical O
properties O
of O
apo B
B I
- I
100 I
and O
will O
facilitate O
studies O
on O
the O
factors O
modulating O
apo B
B I
- I
100 I
biosynthesis O
and O
the O
expression O
of O
the O
apo B
B I
- I
100 I
gene I
in O
patients O
with O
dyslipoproteinemias O
. O

The O
cloning O
of O
human B
apo I
B I
- I
100 I
has O
provided O
new O
insights O
into O
the O
structure O
and O
physicochemical O
properties O
of O
apo B
B I
- I
100 I
and O
will O
facilitate O
studies O
on O
the O
factors O
modulating O
apo B
B I
- I
100 I
biosynthesis O
and O
the O
expression O
of O
the O
apo B
B I
- I
100 I
gene I
in O
patients O
with O
dyslipoproteinemias O
. O

Repeated O
interferon B
- I
beta I
( O
IFN B
- I
beta I
) O
silencer O
B O
motifs O
and O
a O
lysozyme B
silencer I
1 I
motif I
have O
been O
found O
in O
the O
CD95 B
gene I
at O
approximately O
- O
1 O
, O
600 O
and O
- O
1 O
, O
100 O
, O
respectively O
. O

Tax B
and O
the O
active O
Tax B
mutants I
were O
able O
to O
abrogate O
the O
G1 O
arrest O
and O
apoptosis O
induced O
by O
p53 B
, O
and O
this O
effect O
does O
not O
correlate O
with O
an O
altered O
localization O
of O
nuclear B
p53 I
or O
with O
the O
disruption O
of O
p53 B
- I
DNA I
complexes I
. O

Biochemical O
studies O
have O
identified O
a O
cellular O
non B
- I
P I
element I
- I
encoded I
DNA I
binding I
protein I
, O
termed O
the O
inverted B
repeat I
binding I
protein I
( O
IRBP B
) O
, O
that O
specifically O
interacts O
with O
the O
outer O
half O
of O
the O
31 O
- O
bp O
terminal O
inverted O
repeats O
. O

Due O
to O
significant O
homology O
to O
the O
C O
- O
terminus O
of O
the O
Mutator B
transposase I
this O
alternative O
gene O
product O
was O
named O
Trap B
( O
transposon B
- I
associated I
protein I
) O
. O

Subsequent O
analysis O
revealed O
that O
MyD88 B
possesses O
a O
unique O
modular O
structure O
, O
which O
consists O
of O
an O
N O
- O
terminal O
" O
death O
domain O
, O
" O
similar O
to O
the O
intracellular O
segments O
of O
TNF B
receptor I
1 I
and O
Fas B
, O
and O
a O
C O
- O
terminal O
region O
related O
to O
the O
cytoplasmic O
domains O
of O
the O
Drosophila B
morphogen I
Toll I
and O
vertebrate O
interleukin B
- I
1 I
receptors I
. O

RT O
- O
PCR O
analysis O
of O
FGFR B
- I
3 I
mRNA I
showed O
the O
presence O
of O
a O
splice O
variant O
in O
which O
exons O
7 O
and O
8 O
are O
deleted O
. O

Analysis O
of O
the O
MCV B
- I
1 I
RPO1 I
revealed O
high O
amino O
acid O
homologies O
to O
the O
corresponding O
polypeptides O
of O
vaccinia O
and O
variola O
virus O
. O

The O
p58 B
( O
PITSLRE B
beta I
1 I
) O
protein O
kinase O
( O
PK O
) O
is O
a O
member O
of O
a O
large O
supergene O
family O
related O
to O
the O
master B
mitotic I
protein I
kinase I
, O
p34cdc2 B
. O

In O
contrast O
, O
NF B
- I
kappa I
B I
activation O
was O
observed O
in O
these O
cells O
after O
PMA O
stimulation O
. O

The O
plants O
were O
then O
brought O
to O
our O
Houston O
laboratory O
where O
they O
were O
measured O
and O
analyzed O
for O
lignin O
and O
protein O
content O
and O
for O
phenylalanine B
ammonia I
- I
lyase I
( O
PAL B
) O
and O
peroxidase B
activities O
. O

Pax B
- I
6 I
constructs O
lacking O
the O
C O
- O
terminal O
activation O
domain O
repressed O
betaB1 B
- I
crystallin I
promoter I
activity O
as O
effectively O
as O
the O
full O
- O
length O
protein O
, O
but O
the O
PD B
alone O
or O
Pax B
- I
6 I
( I
5a I
) I
, O
a O
splice O
variant O
with O
an O
altered O
PD B
affecting O
its O
DNA O
binding O
specificity O
, O
did O
not O
. O

We O
report O
on O
a O
case O
of O
a O
43 O
- O
old O
- O
male O
with O
a O
bronchogenic O
cyst O
in O
the O
distal O
esophagus O
, O
which O
was O
misdiagnosed O
as O
a O
malignant O
esophageal O
tumor O
based O
on O
preoperative O
imaging O
and O
high O
levels O
of O
the O
tumor O
markers O
CA B
19 I
- I
9 I
and O
CA B
125 I
. O

The O
entire O
coding O
region O
of O
an O
ovine B
endometrial I
oxytocin I
receptor I
( O
OTR B
) O
cDNA O
was O
generated O
by O
PCR O
, O
subcloned O
into O
the O
SV40 B
major I
late I
promoter I
expression O
vector O
pSVLJ O
and O
transiently O
expressed O
in O
Cos O
- O
7 O
cells O
. O

The O
entire O
coding O
region O
of O
an O
ovine B
endometrial I
oxytocin I
receptor I
( O
OTR B
) O
cDNA O
was O
generated O
by O
PCR O
, O
subcloned O
into O
the O
SV40 B
major I
late I
promoter I
expression O
vector O
pSVLJ O
and O
transiently O
expressed O
in O
Cos O
- O
7 O
cells O
. O

Transcriptional O
modulation O
of O
the O
anti B
- I
apoptotic I
protein I
BCL I
- I
XL I
by O
the O
paired B
box I
transcription I
factors I
PAX3 B
and O
PAX3 B
/ O
FKHR B
. O

Genetic O
polymorphisms O
in O
the O
5 O
' O
- O
flanking O
region O
change O
transcriptional O
regulation O
of O
the O
human B
cytochrome I
P450IIE1 I
gene I
. O

Antinuclear O
antibodies O
, O
rheumatoid B
factor I
and O
C B
- I
reactive I
protein I
in O
serum O
of O
normal O
women O
using O
oral O
contraceptives O
. O

Expression O
of O
the O
gene O
encoding O
transcription B
factor I
cyclic I
adenosine I
3 I
' I
, I
5 I
' I
- I
monophosphate I
( I
cAMP I
) I
response I
element I
- I
binding I
protein I
( O
CREB B
) O
: O
regulation O
by O
follicle B
- I
stimulating I
hormone I
- O
induced O
cAMP O
signaling O
in O
primary O
rat O
Sertoli O
cells O
. O

From O
a O
chromosomal O
cosmid O
library O
of O
Streptomyces O
argillaceus O
, O
a O
Mtm B
producer O
, O
a O
clone O
( O
cosAR7 O
) O
was O
isolated O
by O
homology O
to O
the O
actI B
/ I
III I
region I
of O
S O
. O
coelicolor O
and O
the O
strDEM B
genes I
of O
S O
. O
griseus O
. O

In O
this O
report O
, O
we O
investigated O
whether O
the O
cleavage O
of O
the O
RRKR O
motif O
of O
MT B
- I
MMP1 I
by O
Golgi B
- I
associated I
furin I
is O
analogous O
to O
a O
similar O
enzyme O
activation O
mechanism O
observed O
with O
stromelysin B
- I
3 I
. O

Coexpression O
of O
C B
/ I
EBP I
alpha I
altered O
the O
cell O
specificity O
. O

The O
CBS B
- I
1 I
gene I
was O
mapped O
to O
human O
chromosome O
10p12 O
between O
markers O
WI B
- I
8535 I
and O
WI B
- I
4724 I
, O
and O
is O
tightly O
linked O
to O
the O
two O
STRP O
markers O
of O
D10S1789 B
and O
D10S550 B
. O

The O
MEF B
- I
2 I
proteins I
are O
a O
family O
of O
transcriptional O
activators O
that O
have O
been O
detected O
in O
a O
wide O
variety O
of O
cell O
types O
. O

Vertebrate O
U6 B
small I
nuclear I
RNA I
( O
snRNA O
) O
loci O
exemplify O
a O
novel O
class O
of O
polymerase B
III I
- O
transcribed O
genes O
that O
lack O
an O
intragenic O
control O
region O
( O
ICR O
) O
. O

However O
, O
the O
pre3 B
- I
2 I
mutation I
strengthened O
phenotypes O
induced O
by O
other O
20 B
S I
proteasomal I
mutations I
, O
indicating O
that O
the O
peptidylglutamyl O
peptide O
- O
hydrolyzing O
activity O
has O
to O
fulfill O
some O
rescue O
functions O
. O

However O
, O
the O
pre3 B
- I
2 I
mutation I
strengthened O
phenotypes O
induced O
by O
other O
20 B
S I
proteasomal I
mutations I
, O
indicating O
that O
the O
peptidylglutamyl O
peptide O
- O
hydrolyzing O
activity O
has O
to O
fulfill O
some O
rescue O
functions O
. O

The O
tro B
operon I
is O
flanked O
by O
a O
Holliday B
structure I
DNA I
helicase I
homolog O
( O
upstream O
) O
and O
two O
ORFs O
representing O
a O
purine B
nucleoside I
phosphorylase I
homolog O
and O
tpp15 B
, O
a O
previously O
characterized O
gene O
encoding O
a O
membrane O
lipoprotein O
( O
downstream O
) O
. O

These O
include O
the O
genes O
, O
undefined B
1 I
( O
UD1 B
) O
, O
UD2 B
, O
and O
UD3 B
, O
each O
coding O
for O
proteins O
of O
unknown O
function O
, O
the O
ken B
gene I
encoding O
a O
new O
Kruppel B
- I
like I
putative I
transcription I
factor I
, O
the O
fly O
homologues O
of O
the O
mammalian B
mitochondrial I
trifunctional I
enzyme I
( O
thiolase B
) O
, O
and O
the O
TAR B
DNA I
- I
binding I
protein I
- I
43 I
( O
TBPH B
) O
, O
the O
first O
nonvertebrate O
member O
of O
the O
transmembrane B
4 I
superfamily I
( O
TM4SF B
) O
gene O
, O
a O
new O
homeodomain B
gene I
, O
and O
a O
gene O
coding O
for O

a O
putative O
nuclear O
binding O
protein O
( O
PNBP O
) O
that O
is O
homologous O
to O
maleless B
, O
and O
a O
Copia B
- I
like I
element I
. O

RXRalpha B
/ O
RARalpha B
heterodimers O
and O
HNF B
- I
4 I
homodimers I
bind O
to O
DR O
- O
1 O
motifs O
on O
elements O
B O
and O
I4 O
, O
respectively O
. O

Despite O
this O
dependency O
, O
however O
, O
a O
B B
. I
japonicum I
fixK I
mutant I
did O
not O
have O
the O
phenotypic O
characteristics O
of O
B B
. I
japonicum I
fixL I
and O
fixJ B
mutants I
: O
the O
fixK B
mutant I
was O
neither O
Fix O
- O
in O
symbiosis O
with O
soybean O
plants O
nor O
defective O
in O
anaerobic O
respiration O
with O
nitrate O
as O
the O
terminal O
electron O
acceptor O
. O

Similarly O
, O
interfering O
with O
MEKK B
, O
which O
lies O
upstream O
of O
JNK1 B
, O
using O
a O
dominant O
negative O
expression O
vector O
reduced O
MMP B
- I
9 I
promoter I
activity O
over O
the O
same O
concentration O
range O
which O
repressed O
the O
AP B
- I
1 I
- O
thymidine B
kinase I
CAT B
reporter O
construct O
. O

The O
broad O
range O
protein B
tyrosine I
kinase I
inhibitor O
genistein O
and O
the O
phosphatidylinositol B
3 I
- I
kinase I
inhibitors O
wortmannin O
and O
LY O
294002 O
( O
2 O
- O
( O
4 O
- O
morpholinyl O
) O
- O
8 O
- O
phenyl O
- O
4H O
- O
1 O
- O
benzopyran O
- O
4 O
- O
one O
) O
also O
blocked O
adenosine B
A3 I
receptor I
stimulation O
of O
p42 B
/ O
p44 B
MAPK O
. O

The O
organelles O
synthesize O
their O
own O
set O
of O
Fe B
/ I
S I
proteins I
, O
and O
they O
initiate O
the O
generation O
of O
extramitochondrial B
Fe I
/ I
S I
proteins I
. O

A O
genomic O
clone O
of O
the O
chicken B
osteopontin I
- I
encoding I
gene I
( O
opn B
) O
was O
isolated O
and O
found O
to O
be O
organized O
as O
follows O
: O
an O
untranslated O
5 O
' O
exon O
; O
a O
signal O
peptide O
; O
a O
recognition O
sequence O
for O
phosphorylation O
by O
casein B
kinase I
II I
; O
a O
domain O
containing O
a O
possible O
O O
- O
linkage O
site O
for O
glycosylation O
; O
a O
second O
casein B
kinase I
II I
phosphorylation I
site I
; O
an O
exon O
containing O
three O
functional O
regions O
, O
the O
poly O
- O
Asp O
sequence O
of O
seven O
consecutive O
Asp O
residues O
, O
the O
RGD B
integrin I
recognition I
site I
and O
a O
potential O
N O

In O
addition O
, O
while O
GCN1 B
is O
required O
in O
vivo O
for O
phosphorylation O
of O
eIF B
- I
2 I
alpha I
by O
GCN2 B
, O
cell O
extracts O
from O
gcn1 B
delta I
strains O
contained O
wild O
- O
type O
levels O
of O
GCN2 B
eIF B
- I
2 I
alpha I
- O
kinase O
activity O
. O

In O
addition O
, O
while O
GCN1 B
is O
required O
in O
vivo O
for O
phosphorylation O
of O
eIF B
- I
2 I
alpha I
by O
GCN2 B
, O
cell O
extracts O
from O
gcn1 B
delta I
strains O
contained O
wild O
- O
type O
levels O
of O
GCN2 B
eIF B
- I
2 I
alpha I
- O
kinase O
activity O
. O

Cross O
- O
talk O
between O
transcription O
factors O
NF B
- I
kappa I
B I
and O
C B
/ I
EBP I
in O
the O
transcriptional O
regulation O
of O
genes O
. O

The O
Xenopus B
homeobox I
gene I
twin I
mediates O
Wnt B
induction O
of O
goosecoid B
in O
establishment O
of O
Spemann O
' O
s O
organizer O
. O

The O
data O
also O
suggest O
that O
gamma B
CACCC I
box I
binding I
factors I
mediate O
LCR B
- I
gamma I
interactions O
which O
normally O
enhance O
gamma B
- I
globin I
and O
suppress O
beta B
- I
globin I
gene I
expression O
in O
fetal O
erythroid O
cells O
. O

The O
gamma B
- I
GCS I
gene I
is O
expressed O
ubiquitously O
and O
induced O
coordinately O
with O
NAD B
( I
P I
) I
H I
: I
quinone I
oxidoreductase I
( I
1 I
) I
( O
NQO1 B
) O
and O
glutathione B
S I
- I
transferase I
Ya I
( O
GST B
Ya I
) O
in O
response O
to O
xenobiotics O
and O
antioxidants O
. O

Therefore O
, O
in O
VDR B
- O
mediated O
transcriptional O
activation O
, O
1 O
, O
25 O
( O
OH O
) O
2D3 O
binding O
to O
VDR B
alters O
the O
conformation O
of O
the O
ligand O
binding O
domain O
such O
that O
it O
: O
( O
i O
) O
engages O
in O
strong O
heterodimerization O
with O
RXR B
to O
facilitate O
VDRE O
binding O
, O
( O
ii O
) O
influences O
the O
RXR B
ligand I
binding I
domain I
such O
that O
it O
is O
resistant O
to O
the O
binding O
of O
9 O
- O
cis O
RA O
but O
active O
in O
recruiting O
coactivator O
to O
its O
AF O
- O
2 O
and O
( O
iii O
) O
presents O
the O
AF O
- O
2 O
region O
in O
VDR B
for O
coactivator O
association O
. O

The O
predicted O
amino O
acid O
sequence O
of O
the O
FlaB2 B
polypeptide I
was O
92 O
% O
identical O
to O
that O
of O
T B
. I
pallidum I
FlaB2 I
, O
with O
a O
76 O
% O
identity O
at O
the O
nucleotide O
level O
. O

Partial O
proteolysis O
of O
cell O
surface O
- O
iodinated O
B B
- I
G I
molecules I
generates O
extremely O
similar O
patterns O
of O
spots O
, O
both O
within O
and O
between O
haplotypes O
. O

This O
difference O
between O
SP B
- I
1 I
and O
SP B
- I
2 I
peptides I
was O
not O
due O
to O
their O
differential O
uptake O
by O
cell O
, O
since O
approximately O
100 O
times O
more O
SP B
- I
2 I
peptide I
could O
be O
found O
in O
cytoplasmic O
extracts O
than O
SP B
- I
1 I
peptide I
in O
experiments O
using O
radiolabeled O
peptides O
. O

This O
difference O
between O
SP B
- I
1 I
and O
SP B
- I
2 I
peptides I
was O
not O
due O
to O
their O
differential O
uptake O
by O
cell O
, O
since O
approximately O
100 O
times O
more O
SP B
- I
2 I
peptide I
could O
be O
found O
in O
cytoplasmic O
extracts O
than O
SP B
- I
1 I
peptide I
in O
experiments O
using O
radiolabeled O
peptides O
. O

This O
difference O
between O
SP B
- I
1 I
and O
SP B
- I
2 I
peptides I
was O
not O
due O
to O
their O
differential O
uptake O
by O
cell O
, O
since O
approximately O
100 O
times O
more O
SP B
- I
2 I
peptide I
could O
be O
found O
in O
cytoplasmic O
extracts O
than O
SP B
- I
1 I
peptide I
in O
experiments O
using O
radiolabeled O
peptides O
. O

The O
1031 B
- I
bp I
wild I
- I
type I
HIT1 I
DNA I
which O
contained O
an O
open O
reading O
frame O
encoding O
a O
protein O
of O
164 O
amino O
acids O
and O
the O
AGG B
arginine I
tRNA I
gene I
complemented O
all O
hit1 B
- I
1 I
mutant I
phenotypes I
, O
indicating O
that O
the O
mutant O
phenotypes O
were O
caused O
by O
the O
deletion O
of O
these O
genes O
. O

Alignment O
of O
the O
rat B
and I
human I
WIN I
cDNAs I
and O
their O
comparison O
with O
mouse O
genomic O
sequence O
revealed O
that O
the O
WIN B
DNA I
binding I
domain I
is O
encoded O
by O
four O
exons O
, O
two O
of O
which O
( O
exons O
4 O
and O
6 O
) O
are O
alternatively O
spliced O
to O
generate O
at O
least O
three O
classes O
of O
mRNA O
transcripts O
. O

The O
immediate O
5 O
' O
- O
flanking O
region O
was O
GC O
- O
rich O
with O
3 O
SP B
- I
1 I
- I
like I
and O
2 O
AP B
- I
2 I
sites I
identified O
in O
close O
proximity O
to O
the O
transcription O
start O
site O
. O

RESULTS O
: O
Although O
low O
levels O
of O
vIRF B
- I
2 I
mRNAs I
can O
be O
detected O
in O
the O
HHV O
- O
8 O
- O
positive O
BCBL O
- O
1 O
tumor O
cell O
line O
, O
12 O
- O
0 O
- O
tetradecanoylphorbol O
- O
13 O
- O
acetate O
( O
TPA O
) O
treatment O
does O
not O
stimulate O
expression O
of O
vIRF B
- I
2 I
gene I
together O
with O
primary O
lytic O
cycle O
genes O
. O

RESULTS O
: O
Although O
low O
levels O
of O
vIRF B
- I
2 I
mRNAs I
can O
be O
detected O
in O
the O
HHV O
- O
8 O
- O
positive O
BCBL O
- O
1 O
tumor O
cell O
line O
, O
12 O
- O
0 O
- O
tetradecanoylphorbol O
- O
13 O
- O
acetate O
( O
TPA O
) O
treatment O
does O
not O
stimulate O
expression O
of O
vIRF B
- I
2 I
gene I
together O
with O
primary O
lytic O
cycle O
genes O
. O

A O
yeast O
mitochondrial O
translation O
initiation O
codon O
mutation O
affecting O
the O
gene O
for O
cytochrome B
oxidase I
subunit I
III I
( O
COX3 B
) O
was O
partially O
suppressed O
by O
a O
spontaneous O
nuclear O
mutation O
. O

Analysis O
of O
rat O
brain O
, O
heart O
, O
lung O
, O
liver O
, O
kidney O
and O
skeletal O
muscle O
revealed O
psi B
PKC I
zeta I
mRNA I
only O
in O
brain O
. O

Since O
1985 O
the O
combination O
of O
chlorambucil O
( O
10 O
mg O
daily O
, O
initially O
for O
six O
weeks O
, O
then O
alternating O
fortnights O
for O
12 O
weeks O
) O
and O
interferon B
- I
alpha I
2b I
( O
Schering O
- O
Plough O
; O
2 O
x O
10 O
( O
6 O
) O
U O
/ O
m2 O
three O
times O
weekly O
by O
subcutaneous O
injection O
for O
18 O
weeks O
) O
has O
been O
compared O
in O
a O
randomised O
trial O
with O
chlorambucil O
alone O
in O
previously O
untreated O
patients O
with O
stage O
III O
or O
IV O
follicular O
lymphoma O
. O

We O
compared O
retrospectively O
the O
efficacy O
of O
granulocyte B
colony I
stimulating I
factor I
( O
G B
- I
CSF I
) O
alone O
with O
chemotherapy O
plus O
G B
- I
CSF I
in O
mobilizing O
CD34 B
- O
positive O
cells O
in O
patients O
with O
malignant O
lymphoma O
. O

We O
now O
show O
that O
purified O
recombinant O
c B
- I
sis I
/ O
PDGF B
can O
induce O
this O
binding O
activity O
which O
we O
have O
termed O
SIF B
, O
for O
sis B
- I
inducible I
factor I
. O

The O
orthologs O
of O
the O
Y B
( I
1 I
) I
and O
Y B
( I
2 I
) I
subtypes I
display O
high O
amino O
acid O
sequence O
identities O
between O
pig O
, O
human O
, O
and O
mouse O
( O
92 O
% O
- O
94 O
% O
) O
, O
whereas O
the O
Y B
( I
4 I
) I
, O
Y B
( I
5 I
) I
, O
and O
y B
( I
6 I
) I
subtypes I
display O
lower O
identities O
( O
76 O
% O
- O
87 O
% O
) O
. O

The O
orthologs O
of O
the O
Y B
( I
1 I
) I
and O
Y B
( I
2 I
) I
subtypes I
display O
high O
amino O
acid O
sequence O
identities O
between O
pig O
, O
human O
, O
and O
mouse O
( O
92 O
% O
- O
94 O
% O
) O
, O
whereas O
the O
Y B
( I
4 I
) I
, O
Y B
( I
5 I
) I
, O
and O
y B
( I
6 I
) I
subtypes I
display O
lower O
identities O
( O
76 O
% O
- O
87 O
% O
) O
. O

The O
orthologs O
of O
the O
Y B
( I
1 I
) I
and O
Y B
( I
2 I
) I
subtypes I
display O
high O
amino O
acid O
sequence O
identities O
between O
pig O
, O
human O
, O
and O
mouse O
( O
92 O
% O
- O
94 O
% O
) O
, O
whereas O
the O
Y B
( I
4 I
) I
, O
Y B
( I
5 I
) I
, O
and O
y B
( I
6 I
) I
subtypes I
display O
lower O
identities O
( O
76 O
% O
- O
87 O
% O
) O
. O

LCCH1 B
was O
identical O
to O
the O
Rdl B
gene I
, O
a O
known O
GABA B
receptor I
subunit I
gene I
from O
D O
. O
melanogaster O
, O
whereas O
LCCH2 B
and O
LCCH3 B
were O
novel O
D O
. O
melanogaster O
sequences O
that O
exhibited O
structural O
similarity O
to O
other O
members O
of O
the O
ligand B
- I
gated I
chloride I
channel I
gene I
family I
. O

Electrophoretic O
mobility O
- O
shift O
assays O
showed O
a O
rapid O
induction O
of O
nuclear O
proteins O
that O
bound O
to O
the O
consensus B
kappa I
B I
motif I
. O

The O
major O
open O
reading O
frame O
of O
the O
cDNA O
predicts O
a O
protein O
of O
59 O
kD O
, O
with O
a O
leucine O
zipper O
situated O
adjacent O
to O
an O
myc B
- I
related I
motif I
that O
has O
been O
proposed O
to O
assume O
a O
helix O
- O
loop O
- O
helix O
structure O
. O

Promoter O
activity O
of O
the O
proliferating B
- I
cell I
nuclear I
antigen I
gene I
is O
associated O
with O
inducible O
CRE B
- I
binding I
proteins I
in O
interleukin B
2 I
- O
stimulated O
T O
lymphocytes O
. O

